<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:41:52Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:3182920" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:3182920</identifier><datestamp>2011-10-06</datestamp><setSpec>plospath</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">PLoS Pathog</journal-id>
      <journal-id journal-id-type="iso-abbrev">PLoS Pathog</journal-id>
      <journal-id journal-id-type="publisher-id">plos</journal-id>
      <journal-id journal-id-type="pmc">plospath</journal-id>
      <journal-title-group>
        <journal-title>PLoS Pathogens</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1553-7366</issn>
      <issn pub-type="epub">1553-7374</issn>
      <publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC3182920</article-id>
      <article-id pub-id-type="pmcid">PMC3182920</article-id>
      <article-id pub-id-type="pmc-uid">3182920</article-id>
      <article-id pub-id-type="pmid">21980294</article-id>
      <article-id pub-id-type="pmid">21980294</article-id>
      <article-id pub-id-type="publisher-id">PPATHOGENS-D-11-00917</article-id>
      <article-id pub-id-type="doi">10.1371/journal.ppat.1002277</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Biology</subject>
          <subj-group>
            <subject>Biochemistry</subject>
            <subj-group>
              <subject>Proteins</subject>
              <subj-group>
                <subject>Protein Structure</subject>
              </subj-group>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Microbiology</subject>
            <subj-group>
              <subject>Virology</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Structure of Herpes Simplex Virus Glycoprotein D Bound to the Human Receptor Nectin-1</article-title>
        <alt-title alt-title-type="running-head">Structure of HSV-1 gD Bound to Nectin-1</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Di Giovine</surname>
            <given-names>Paolo</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Settembre</surname>
            <given-names>Ethan C.</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bhargava</surname>
            <given-names>Arjun K.</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Luftig</surname>
            <given-names>Micah A.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
          <xref ref-type="author-notes" rid="fn1">
<sup>Â¤a</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lou</surname>
            <given-names>Huan</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cohen</surname>
            <given-names>Gary H.</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Eisenberg</surname>
            <given-names>Roselyn J.</given-names>
          </name>
          <xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Krummenacher</surname>
            <given-names>Claude</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
          <xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Carfi</surname>
            <given-names>Andrea</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
          <xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref>
          <xref ref-type="author-notes" rid="fn2">
<sup>Â¤b</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
<label>1</label>
<addr-line>Department of Biochemistry and Molecular Biology, IRBM P. Angeletti, Pomezia, Rome, Italy</addr-line>
</aff>
      <aff id="aff2">
<label>2</label>
<addr-line>Protein Biochemistry, Novartis Vaccine and Diagnostics, Cambridge, Massachusetts, United States of America</addr-line>
</aff>
      <aff id="aff3">
<label>3</label>
<addr-line>Department of Biochemistry, School of Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America</addr-line>
</aff>
      <aff id="aff4">
<label>4</label>
<addr-line>Department of Microbiology, School of Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America</addr-line>
</aff>
      <aff id="aff5">
<label>5</label>
<addr-line>Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America</addr-line>
</aff>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Stehle</surname>
            <given-names>Thilo</given-names>
          </name>
          <role>Editor</role>
          <xref ref-type="aff" rid="edit1"/>
        </contrib>
      </contrib-group>
      <aff id="edit1">University of TÃ¼bingen, Germany</aff>
      <author-notes>
        <corresp id="cor1">* E-mail: <email>ckrummen@dental.upenn.edu</email> (CK); <email>andrea.carfi@novartis.com</email> (AC)</corresp>
        <fn id="fn1" fn-type="current-aff">
          <p><bold>Â¤a:</bold> Current address: Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, United States of America</p>
        </fn>
        <fn id="fn2" fn-type="current-aff">
          <p><bold>Â¤b:</bold> Current address: Protein Biochemistry, Novartis Vaccine &amp; Diagnostics, Cambridge, Massachusetts, United States of America</p>
        </fn>
        <fn fn-type="con">
          <p>Conceived and designed the experiments: AC CK RJE GHC PDG. Performed the experiments: PDG AKB MAL HL AC. Analyzed the data: PDG ECS CK AC. Contributed reagents/materials/analysis tools: GHC RJE CK PDG AC. Wrote the paper: CK AC PDG ECS.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="collection">
        <month>9</month>
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>29</day>
        <month>9</month>
        <year>2011</year>
      </pub-date>
      <volume>7</volume>
      <issue>9</issue>
      <elocation-id>e1002277</elocation-id>
      <history>
        <date date-type="received">
          <day>3</day>
          <month>5</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>2</day>
          <month>8</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Di Giovine et al.</copyright-statement>
        <copyright-year>2011</copyright-year>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Binding of herpes simplex virus (HSV) glycoprotein D (gD) to a cell surface receptor is required to trigger membrane fusion during entry into host cells. Nectin-1 is a cell adhesion molecule and the main HSV receptor in neurons and epithelial cells. We report the structure of gD bound to nectin-1 determined by x-ray crystallography to 4.0 Ã resolution. The structure reveals that the nectin-1 binding site on gD differs from the binding site of the HVEM receptor. A surface on the first Ig-domain of nectin-1, which mediates homophilic interactions of Ig-like cell adhesion molecules, buries an area composed by residues from both the gD N- and C-terminal extensions. Phenylalanine 129, at the tip of the loop connecting Î²-strands F and G of nectin-1, protrudes into a groove on gD, which is otherwise occupied by C-terminal residues in the unliganded gD and by N-terminal residues in the gD/HVEM complex. Notably, mutation of Phe129 to alanine prevents nectin-1 binding to gD and HSV entry. Together these data are consistent with previous studies showing that gD disrupts the normal nectin-1 homophilic interactions. Furthermore, the structure of the complex supports a model in which gD-receptor binding triggers HSV entry through receptor-mediated displacement of the gD C-terminal region.</p>
      </abstract>
      <counts>
        <page-count count="13"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <boxed-text id="ppat-1002277-box001" position="float">
      <sec id="s1a">
        <title>Authors Summary</title>
        <p>Herpes simplex virus (HSV) is a widespread human pathogen. Four viral glycoproteins (gD, gB, gH/gL) are required for HSV entry into host cells. gD binding to a cell surface receptor triggers conformational changes in the other viral glycoproteins leading to membrane fusion and viral entry. Two structurally unrelated cellular protein receptors, nectin-1 and HVEM, can mediate HSV entry upon binding to gD. The structure presented here reveals the molecular basis for the stable interaction between HSV-1 gD and the receptor nectin-1. Comparison with the previously determined structures of the gD/HVEM complex and unliganded gD shows that, despite the fact that the two receptors interact with different binding sites, they both cause a similar conformational change in gD. Therefore, our data point to a conserved mechanism for receptor mediated activation of the HSV entry process. In addition, the gD/Nectin-1 structure reveals that the gD-binding site overlaps with a surface involved in nectin-1 homo-dimerization. This observation explains how gD interferes with the cell adhesion function of nectin-1. Finally, the gD/Nectin-1 complex displays similarities with other viral ligands bound to immunoglobulin-like receptors suggesting a convergent mechanism for receptors selection and usage.</p>
      </sec>
    </boxed-text>
    <sec id="s2">
      <title>Introduction</title>
      <p>Herpes simplex virus (HSV) enters cells by fusing its envelope with a membrane of the host cell <xref rid="ppat.1002277-Heldwein1" ref-type="bibr">[1]</xref>. Five viral envelope glycoproteins participate in the cell entry process. First, glycoprotein C (gC) and gB promote attachment by interacting with cell surface proteoglycans, then gD binds to a specific receptor <xref rid="ppat.1002277-Connolly1" ref-type="bibr">[2]</xref>, <xref rid="ppat.1002277-Eisenberg1" ref-type="bibr">[3]</xref>. The gD-receptor interaction initiates the process that ultimately leads to gB-mediated membrane fusion <xref rid="ppat.1002277-Atanasiu1" ref-type="bibr">[4]</xref>, <xref rid="ppat.1002277-Chowdary1" ref-type="bibr">[5]</xref>. Depending on the cell type, fusion occurs at the cell surface or, after endocytosis of virions, with an endosomal membrane in a low pH-dependent or independent manner <xref rid="ppat.1002277-Milne1" ref-type="bibr">[6]</xref>, <xref rid="ppat.1002277-Nicola1" ref-type="bibr">[7]</xref>. Regardless of the entry pathway gD, gB, gH/gL and a cellular gD receptor are required for entry <xref rid="ppat.1002277-Nicola2" ref-type="bibr">[8]</xref>.</p>
      <p>Several cell surface molecules can bind gD and mediate HSV entry into human cells <xref rid="ppat.1002277-Heldwein1" ref-type="bibr">[1]</xref>. The immune modulator HVEM (herpesvirus entry mediator) is a member of the Tumor Necrosis Factor Receptor (TNFR) family and is used by wild type (wt) HSV type 1 (HSV-1) and HSV-2 <xref rid="ppat.1002277-Montgomery1" ref-type="bibr">[9]</xref>. HVEM was the first described herpes simplex virus receptor and is expressed at low levels on fibroblasts and on ocular cell types <xref rid="ppat.1002277-Tiwari1" ref-type="bibr">[10]</xref>, <xref rid="ppat.1002277-Akhtar1" ref-type="bibr">[11]</xref>, <xref rid="ppat.1002277-Krummenacher1" ref-type="bibr">[12]</xref>. However, the cell adhesion molecule nectin-1 (HveC, CD111) is the primary receptor for HSV-1 and HSV-2 on neurons, keratinocytes and epithelial cells <xref rid="ppat.1002277-Krummenacher1" ref-type="bibr">[12]</xref>, <xref rid="ppat.1002277-Simpson1" ref-type="bibr">[13]</xref>, <xref rid="ppat.1002277-Galen1" ref-type="bibr">[14]</xref>, <xref rid="ppat.1002277-Huber1" ref-type="bibr">[15]</xref>. In addition, HSV-1 gD binds to heparan sulfate (HS) specifically modified by 3-O-sulfotransferases (3-OS-HS) <xref rid="ppat.1002277-Tiwari2" ref-type="bibr">[16]</xref>. Recently it has been shown that the interaction between gD and its receptor is not only required to trigger the HSV fusion machinery but also to direct the virus to the endocytic pathway in some cell types <xref rid="ppat.1002277-Milne1" ref-type="bibr">[6]</xref>, <xref rid="ppat.1002277-Delboy1" ref-type="bibr">[17]</xref>, <xref rid="ppat.1002277-Stiles1" ref-type="bibr">[18]</xref>, <xref rid="ppat.1002277-Stiles2" ref-type="bibr">[19]</xref>, <xref rid="ppat.1002277-Stiles3" ref-type="bibr">[20]</xref>.</p>
      <p>We previously reported the structure of HSV-1 gD alone and bound to HVEM <xref rid="ppat.1002277-Carfi1" ref-type="bibr">[21]</xref>, <xref rid="ppat.1002277-Krummenacher2" ref-type="bibr">[22]</xref>. The gD ectodomain consists of 316 residues and is formed by a core with a variable-type immunoglobulin fold (IgV, residues 55 to 185) that is wrapped by a N-terminal extension and a C-terminal proline-rich extension. The first 20 N-terminal residues are flexible and extended in the receptor-free form of gD. However, when gD is bound to HVEM these residues fold back to form a hairpin structure that contains all the amino acids contacting this receptor <xref rid="ppat.1002277-Carfi1" ref-type="bibr">[21]</xref>, <xref rid="ppat.1002277-Connolly2" ref-type="bibr">[23]</xref>. The first 32 N-terminal residues of gD are also involved in binding to 3-OS-HS but are dispensable for nectin-1 binding and usage <xref rid="ppat.1002277-Yoon1" ref-type="bibr">[24]</xref>.</p>
      <p>The C-terminal extension of the gD ectodomain past residue 255 is also flexible and its location and structure were determined after stabilization in a disulfide-bonded gD dimer <xref rid="ppat.1002277-Krummenacher2" ref-type="bibr">[22]</xref>. In this receptor-free structure, the C-terminal region folds back around the core towards the N-terminus and amino acids 280 to 306 fill the space occupied by the N-terminal first 20 residues of gD in the gD/HVEM complex. In this conformation, the C-terminal gD amino acids were positioned directly over several residues previously implicated in nectin-1 binding <xref rid="ppat.1002277-Krummenacher2" ref-type="bibr">[22]</xref>. Despite the key insights into the gD/Nectin-1 interaction obtained from mutagenesis studies a structural model for the gD/Nectin-1 complex has been missing<monospace>.</monospace>
</p>
      <p>The nectin-1 ectodomain spans residues 31 to 346 forming three domains with an Ig-like fold (V-C1âC2) and contains 8 potential sites for N-linked oligosaccharides <xref rid="ppat.1002277-Krummenacher3" ref-type="bibr">[25]</xref>, <xref rid="ppat.1002277-Narita1" ref-type="bibr">[26]</xref>. Chimeric receptor molecules were used to show that the binding site for gD involves mainly the N-terminal V-domain of nectin-1 (residues 31â143) <xref rid="ppat.1002277-Cocchi1" ref-type="bibr">[27]</xref>, <xref rid="ppat.1002277-Krummenacher4" ref-type="bibr">[28]</xref> and that residues 64â94 in particular are part of the binding epitope <xref rid="ppat.1002277-Cocchi2" ref-type="bibr">[29]</xref>. In addition, linear epitopes of two neutralizing monoclonal antibodies directed at nectin-1, CK6 and CK8, were mapped to residues 80â105 <xref rid="ppat.1002277-Krummenacher5" ref-type="bibr">[30]</xref>.</p>
      <p>Nectin-1 form <italic>cis</italic>-dimers at the cell surface to interact with nectin-1 or other nectin family members <italic>in trans</italic> (different cells) at cell junctions <xref rid="ppat.1002277-Takai1" ref-type="bibr">[31]</xref>. The crystal structure of the nectin-1 ectodomain has revealed that the V-domain mediates receptor dimerization <xref rid="ppat.1002277-Narita1" ref-type="bibr">[26]</xref> and it was proposed that these dimers may be representative of the nectin-1 <italic>cis</italic>-interaction <xref rid="ppat.1002277-Narita1" ref-type="bibr">[26]</xref>. Importantly, HSV gD has been shown to interfere with nectin-1 mediated cell-adhesion <xref rid="ppat.1002277-Krummenacher4" ref-type="bibr">[28]</xref>, <xref rid="ppat.1002277-Krummenacher6" ref-type="bibr">[32]</xref>, <xref rid="ppat.1002277-Sakisaka1" ref-type="bibr">[33]</xref>.</p>
      <p>Given the importance of the gD/Nectin-1 interaction in HSV entry and the need to gain insights into how two structurally different receptors, nectin-1 and HVEM, trigger HSV entry we sought to obtain a molecular view of the interaction between gD and nectin-1. Here we present the structure of the gD/Nectin-1 complex determined by x-ray crystallography to 4.0 Ã resolution and accompanying mutagenesis data. The comparison of the new structure with the previously determined gD/HVEM and unliganded gD structures suggests a common mechanism of receptor-induced conformational changes as a trigger of HSV membrane fusion.</p>
    </sec>
    <sec id="s3">
      <title>Results</title>
      <sec id="s3a">
        <title>Structure determination and refinement</title>
        <p>Truncated forms of the gD ectodomain (gD285t, residues 1â285; gD306t, residues 1 to 306; and gD316t, residues 1 to 316) and the full length nectin-1 ectodomain (residues 31â345; <xref ref-type="fig" rid="ppat-1002277-g001">
<bold>Fig. 1A</bold>
</xref>) were used for complex formation and crystallization. Crystals were obtained for the gD285t/Nectin-1 complex whereas the longer forms of gD (i.e. gD306t or gD316t) failed to produce crystals. Previous experiments have demonstrated a 20â40 fold decreased affinity for nectin-1 by gD306t (K<sub>D</sub>â=â1.8 ÂµM) compared to the shorter gD285t (gD285; K<sub>D</sub>â=â70 nM) <xref rid="ppat.1002277-Krummenacher2" ref-type="bibr">[22]</xref>. This decreased affinity and the intrinsic flexibility of C-terminus of the gD ectodomain may have hindered crystallization of the longer forms. In addition, crystals from the gD285t/Nectin-1 complex could not be easily reproduced. The nectin-1 ectodomain contains several consensus N-glycosylation sites (<xref ref-type="fig" rid="ppat-1002277-g001">
<bold>Fig. 1A</bold>
</xref>) and heterogeneity in glycosylation may interfere with crystallization <xref rid="ppat.1002277-Narita1" ref-type="bibr">[26]</xref>. However, attempts to reduce protein heterogeneity by enzymatically deglycosylating nectin-1 produced in insect or mammalian cells did not facilitate crystallization. Ultimately, a 4.0 Ã resolution data set was collected and the structure was determined by the molecular replacement method with the program Phaser <xref rid="ppat.1002277-McCoy1" ref-type="bibr">[34]</xref> and refined with Refmac <xref rid="ppat.1002277-Skubak1" ref-type="bibr">[35]</xref> to an R<italic><sub>free</sub></italic> of 28.9% and R<italic><sub>work</sub></italic> of 26.5% (<bold><xref ref-type="supplementary-material" rid="ppat.1002277.s004">Table S1</xref></bold> and <bold><xref ref-type="supplementary-material" rid="ppat.1002277.s001">Fig. S1</xref></bold>).</p>
        <fig id="ppat-1002277-g001" position="float">
          <object-id pub-id-type="doi">10.1371/journal.ppat.1002277.g001</object-id>
          <label>Figure 1</label>
          <caption>
            <title>Structure of the gD/Nectin-1 complex.</title>
            <p>
<bold>A</bold>. Schematic representations of human nectin-1 and HSV-1 gD. Signal peptides are shown as white boxes and transmembrane regions are shown as hatched boxes. Lollipops represent N-glycosylation sites. For nectin-1, numbering starts at methionine 1 of the open reading frame while for gD it starts at lysine 1 of the mature glycoprotein. Arrowheads indicate the location of truncations for production of nectin-1(346t), gD285t, gD306t and gD316t. Nectin-1 is colored in violet with a region previously implicated in gD binding colored in red. The gD Ig core is in shown in yellow, residues forming the HVEM binding hairpin are in green, residues 39 to 55 from the N-terminal extension are in dark grey, residues 185 to 250 from the C-terminal extension are in light gray and residues 251 to 316 are in red. <bold>B</bold>. Ribbon representation of the gD/Nectin-1 complex. The color code is the same as in <xref ref-type="fig" rid="ppat-1002277-g001">Fig. 1A</xref>. The secondary structure elements are labeled as in Carfi <italic>et al.</italic>
<xref rid="ppat.1002277-Carfi1" ref-type="bibr">[21]</xref>. The Î²-strands are labeled according to the Ig V-fold. Unsolved loops in the distal portion of the nectin-1 C1 domain are drawn as dotted lines.</p>
          </caption>
          <graphic xlink:href="ppat.1002277.g001"/>
        </fig>
      </sec>
      <sec id="s3b">
        <title>Overall structure of the gD/Nectin-1 complex</title>
        <p>The crystals belong to the P3<sub>2</sub>21 space group and contain three gD/Nectin-1 complexes per asymmetric unit. Two complexes form a dimer around a two-fold non-crystallographic symmetry (NCS) axis (<bold><xref ref-type="supplementary-material" rid="ppat.1002277.s002">Fig. S2</xref></bold>) and the third complex forms an equivalent dimer with a crystallographically related molecule. Experiments with purified proteins in solution suggest that these dimers might have formed in the crystals as a result of the high protein concentration and crystal packing interactions and are unlikely to be biologically relevant (see below).</p>
        <p>The structure shows a direct interaction between one monomer of gD and one of nectin-1 <bold>(</bold>
<xref ref-type="fig" rid="ppat-1002277-g001">
<bold>Fig. 1B</bold>
</xref>
<bold>)</bold>. No electron density was observed for residues 1 to 22 and 251 to 285. Both regions are known to be flexible and are presumably disordered in the crystals. In the gD285t/HVEM complex the same C-terminal region of gD was disordered <xref rid="ppat.1002277-Carfi1" ref-type="bibr">[21]</xref>. Moreover, deletions within the first 32 residues of gD do not impair nectin-1 binding and HSV entry in nectin-1 expressing cells <xref rid="ppat.1002277-Spear1" ref-type="bibr">[36]</xref>.</p>
        <p>The gD binding site is located exclusively within the N-terminal V-domain of nectin-1, validating previous predictions from <italic>in vitro</italic> binding and infection assays <xref rid="ppat.1002277-Cocchi1" ref-type="bibr">[27]</xref>, <xref rid="ppat.1002277-Krummenacher4" ref-type="bibr">[28]</xref>, <xref rid="ppat.1002277-Geraghty1" ref-type="bibr">[37]</xref>. The nectin-1 V-domain major axis forms an angle of almost 90Â° with the long axis of the gD IgV-core while the C1 domain points away from gD. The elbow angle between the V and C1 domains is the same as that observed in the unliganded form of nectin-1 <xref rid="ppat.1002277-Narita1" ref-type="bibr">[26]</xref> and differs by approximately 15Â° from what was observed in the structure of the closely related poliovirus receptor (necl-5, CD155) (<bold><xref ref-type="supplementary-material" rid="ppat.1002277.s003">Fig. S3</xref></bold>) <xref rid="ppat.1002277-Zhang1" ref-type="bibr">[38]</xref>. The C2 domain, though present in the crystals of the complex, was not visible in the electron-density maps and is likely to be disordered in the crystals.</p>
      </sec>
      <sec id="s3c">
        <title>The gD/Nectin-1 interface</title>
        <p>Nectin-1 interacts with gD mainly through the side chains of exposed residues. A total of 1665 Ã<sup>2</sup> of surface area, 829 Ã<sup>2</sup> in nectin-1 and 836 Ã<sup>2</sup> in gD, are buried in the complex. This value is within the range observed for other protein/protein complexes and viral glycoprotein/receptor complexes <xref rid="ppat.1002277-Carfi1" ref-type="bibr">[21]</xref>, <xref rid="ppat.1002277-Kwong1" ref-type="bibr">[39]</xref>, <xref rid="ppat.1002277-Bewley1" ref-type="bibr">[40]</xref>, <xref rid="ppat.1002277-Kirchner1" ref-type="bibr">[41]</xref>. Nectin-1 contacts gD exclusively with one Î²-sheet of the V-domain (strands Câ³Câ²CFG) and the intervening loops (<xref ref-type="fig" rid="ppat-1002277-g001">
<bold>Fig. 1B</bold>
</xref>). This Î²-sheet forms an extensive interface with residues from the C- and N-terminal extensions of gD. In particular, the upper part of Î²-strands Câ³Câ² is close to two short gD Î²-strands (Î²2, residues 35â38 and Î²3, residues 219â221) whereas at the bottom part the same strands are in proximity with two short gD helical turns (Î·1, residues 199â201 and Î·2, residues 214â217).</p>
        <p>Additional contacts are established by the loop connecting strands F and G of the nectin-1 V-domain. In particular, a prominent interaction involves Phe129, at the tip of the FG loop, which protrudes into a pocket formed by residues from the long Î±3-helix flanking the IgV-like core of gD and the side chain of Phe223 (<xref ref-type="fig" rid="ppat-1002277-g001">
<bold>Fig. 1B</bold>
</xref> and <xref ref-type="fig" rid="ppat-1002277-g002">
<bold>Fig. 2A, B</bold>
</xref>). Direct interaction with the gD IgV-core is limited and involves only nectin-1 strand Câ³ and the side chains of gD Gln132.</p>
        <fig id="ppat-1002277-g002" position="float">
          <object-id pub-id-type="doi">10.1371/journal.ppat.1002277.g002</object-id>
          <label>Figure 2</label>
          <caption>
            <title>The gD/Nectin-1 and Nectin-1/Nectin-1 interfaces.</title>
            <p>
<bold>A</bold>. Representation of the gD/Nectin-1 interface with key contact residues labeled and displayed in stick representation. Nectin-1 and gD are colored as in <xref ref-type="fig" rid="ppat-1002277-g001">Fig. 1</xref>. <bold>B</bold>. Surface representation of gD showing the interface with nectin-1. gD is colored as in <xref ref-type="fig" rid="ppat-1002277-g001">Fig. 1</xref> with the nectin-1 contact area represented in blue and magenta. Mutations of residues colored blue have been shown to affect nectin-1 binding. Involvement of residues colored magenta has not previously been proposed. Most of the contacts involve residues from the gD C-terminal extension and, Y38 and Q27 from the N-terminal extension. <bold>C</bold>. Representation of a portion of the nectin-1 dimer interface (pdb-id 3ALP). Residues involved in key dimer interactions and that are involved in the gD/Nectin-1 interface are shown in stick representation. One monomer of nectin-1 is colored orange with black labels and the other is in pink with gray labels. <bold>D</bold>. Surface representation of the nectin-1 V-domain highlighting residues involved in either gD binding (magenta, left panel) or nectin-1 dimerization (orange, right panel).</p>
          </caption>
          <graphic xlink:href="ppat.1002277.g002"/>
        </fig>
      </sec>
      <sec id="s3d">
        <title>The gD/Nectin-1 structure and previous mutagenesis studies</title>
        <p>The structure of the gD/Nectin-1 complex explains the results of previous mutagenesis experiments. On the nectin-1 V-domain, strands Câ³Câ²C were predicted to be involved in gD binding based on epitope mapping and chimeric receptor analysis <xref rid="ppat.1002277-Cocchi2" ref-type="bibr">[29]</xref>, <xref rid="ppat.1002277-Krummenacher5" ref-type="bibr">[30]</xref>, <xref rid="ppat.1002277-Spear1" ref-type="bibr">[36]</xref>, <xref rid="ppat.1002277-Menotti1" ref-type="bibr">[42]</xref> (<xref ref-type="fig" rid="ppat-1002277-g001">
<bold>Fig. 1B</bold>
</xref>). In addition, site-directed mutagenesis identified residues important for nectin-1 binding and usage between positions 64 and 94 <xref rid="ppat.1002277-Cocchi2" ref-type="bibr">[29]</xref>. Notably, nectin-1 residues Asn77 and Met85, which mutations to alanine hindered HSV entry <xref rid="ppat.1002277-Martinez1" ref-type="bibr">[43]</xref>, are now found at the interface with gD (<xref ref-type="fig" rid="ppat-1002277-g002">
<bold>Fig. 2A</bold>
</xref>). On gD a number of residues have been shown to affect nectin-1 binding (<xref ref-type="fig" rid="ppat-1002277-g002">
<bold>Fig. 2A, B</bold>
</xref>). For instance, gD Tyr38 side chain, a critical residue for nectin-1 binding, is located near the receptor Câ³ strand and Met85 (<xref ref-type="fig" rid="ppat-1002277-g002">
<bold>Fig. 2A</bold>
</xref>). Furthermore, residues Asp215 and Arg222/Phe223 of gD, contact the receptor Î²-strands Câ³Câ² and the FG loop respectively. The structural data explain the phenotype of a triple mutant of gD, which combined mutations of these residues prevent nectin-1 usage <xref rid="ppat.1002277-Spear1" ref-type="bibr">[36]</xref>, <xref rid="ppat.1002277-Uchida1" ref-type="bibr">[44]</xref>. In particular, the side chain of Arg222 of gD is in salt bridge distance of nectin-1 Glu125 (<xref ref-type="fig" rid="ppat-1002277-g002">
<bold>Fig. 2A</bold>
</xref>) consistent with the decrease in gD/Nectin-1 binding affinity seen when Arg222 was mutated to alanine <xref rid="ppat.1002277-Whitbeck1" ref-type="bibr">[<bold>45]</bold>
</xref>, <xref rid="ppat.1002277-Connolly3" ref-type="bibr">[46<bold/>]</xref>. Finally, mutation of nectin-1 Phe129 to leucine, a structurally conservative mutation, was found to impair gD binding, although this form of nectin-1 retained some receptor activity <xref rid="ppat.1002277-Narita1" ref-type="bibr">[26]</xref>, <xref rid="ppat.1002277-Struyf1" ref-type="bibr">[47]</xref>. The gD/Nectin-1 structure demonstrates the critical location of this residue at the interface with gD.</p>
      </sec>
      <sec id="s3e">
        <title>Comparison of the gD/Nectin-1 and Nectin-1/Nectin-1 interface</title>
        <p>The structures of the nectin-1 dimer and the gD/Nectin-1 complex reveal similarities between their interfaces. Indeed gD contacts many of the same residues involved in nectin-1 dimerization (<xref ref-type="fig" rid="ppat-1002277-g002">
<bold>Fig. 2A, C</bold>
</xref>) and buries a similar surface area on the receptor (1665 Ã<sup>2</sup> vs. 1686 Ã<sup>2</sup>) (<xref ref-type="fig" rid="ppat-1002277-g002">
<bold>Fig. 2D</bold>
</xref>). In the nectin-1 homo-dimer several hydrogen bonds, two salt bridges (between Lys75 and Glu135), and a number of van der Waals interactions involving Thr63, Phe129 and Met85 are present <xref rid="ppat.1002277-Narita1" ref-type="bibr">[26]</xref> (<xref ref-type="fig" rid="ppat-1002277-g002">
<bold>Fig. 2C</bold>
</xref>). In the complex, both Thr63 and Phe129 of nectin-1 establish van der Waals interactions with Phe233 of gD whereas Met85 is in proximity of gD Tyr38. In addition, in the nectin-1 homodimer two inter-molecular salt bridges between Lys75 and Glu135 are present whereas two Glu125 residues make a potentially unfavorable interaction as they are buried at the dimer interface (<xref ref-type="fig" rid="ppat-1002277-g002">
<bold>Fig. 2C</bold>
</xref>). In the complex, the nectin-1 Lys75-Glu135 salt bridge forms intra-molecularly and a new inter-molecular salt bridge is formed between Glu125 of nectin-1 and Arg222 of gD. Therefore, nectin-1 binding to gD leads to the replacement of the potentially unfavorable Glu125-Glu125 interaction at the nectin-1 dimer interface and formation of a new salt bridge (<xref ref-type="fig" rid="ppat-1002277-g002">
<bold>Fig. 2A, C</bold>
</xref>).</p>
      </sec>
      <sec id="s3f">
        <title>Stoichiometry of the gD/Nectin-1 complex and effects of gD binding on nectin-1 homo-dimerization</title>
        <p>The Î²-sheet of the nectin-1 V-domain that contacts gD has been implicated in mediating homophilic and heterophilic trans-interactions in other Ig-superfamily members involved in cell adhesion (e.g. necl-1 <xref rid="ppat.1002277-Dong1" ref-type="bibr">[48]</xref>, CAR <xref rid="ppat.1002277-vanRaaij1" ref-type="bibr">[49]</xref>, JAM <xref rid="ppat.1002277-Kirchner1" ref-type="bibr">[41]</xref> and SLAM <xref rid="ppat.1002277-Hashiguchi1" ref-type="bibr">[50]</xref>). The same surface on the nectin-1 V-domain has been shown to mediate its dimerization <xref rid="ppat.1002277-Narita1" ref-type="bibr">[26]</xref> (<xref ref-type="fig" rid="ppat-1002277-g002">
<bold>Fig. 2D</bold>
</xref>). Together these data are consistent with gD binding preventing nectin-1 from interacting with itself as previously suggested by size exclusion chromatography (SEC) experiments <xref rid="ppat.1002277-Krummenacher3" ref-type="bibr">[25]</xref>, <xref rid="ppat.1002277-Krummenacher4" ref-type="bibr">[28]</xref>.</p>
        <p>To analyze the stoichiometry of gD/Nectin-1 binding in solution and to gain further insights into the effects of gD binding on nectin-1 oligomerization and homophilic interaction, we combined SEC with multi-angle light scattering analysis (MALS). Differently from SEC, which is dependent on the hydrodynamic radius of molecules, MALS is not affected by the shape of the molecules and provides with the absolute molar mass of the particles measured. The elution volume of the nectin-1 ectodomain (MW 40 kDa) in SEC experiments suggested an apparent MW of 115 kDa, however MALS revealed a MW of 71 kDa (data not shown). Together these data are consistent with nectin-1 forming an elongated dimer in solution as revealed by the crystal structure <xref rid="ppat.1002277-Narita1" ref-type="bibr">[26]</xref>. MALS of the gD/Nectin-1 complex yielded a MW of 72 kDa in line with the formation of a 1â¶1 complex of monomers (data not shown). These analyses are in agreement with previous experiments demonstrating that gD binding prevents functional nectin-1 homo-dimerization and interferes with nectin-1 mediated cell adhesion <xref rid="ppat.1002277-Krummenacher6" ref-type="bibr">[32]</xref>, <xref rid="ppat.1002277-Sakisaka1" ref-type="bibr">[33]</xref> and support the notion that the gD/Nectin-1 dimers, seen in the crystals, are not formed in solution (<bold><xref ref-type="supplementary-material" rid="ppat.1002277.s002">Fig. S2</xref></bold>).</p>
      </sec>
      <sec id="s3g">
        <title>Mutations of nectin-1 and effect on gD binding</title>
        <p>To gain additional insight into the involvement of specific amino acids in the formation of a stable gD/Nectin-1 complex and to assess the relative contribution of the CCâ²Câ³ region versus the FG loop, we targeted four nectin-1 residues located at the interface with gD for mutagenesis. We hypothesized that the CCâ²Câ³ region would rely less on single residues for binding and that the protruding phenyl ring of Phe129 was critical for function. Thus we selected Thr66, Asn82, Ser84 in the CCâ²Câ³ region and Phe129 at the tip of the FG loop (<xref ref-type="fig" rid="ppat-1002277-g002">
<bold>Fig. 2A</bold>
</xref>). Ser84 was mutated to tyrosine (S84Y) or arginine (S84R), Asn82 was mutated to a threonine (N82T) and Thr66 to glutamine (T66Q). The changes in the size of the side chains at these positions were designed to destabilize the interaction with gD either by steric obstruction or by interfering with the formation of hydrogen bonds. On the other hand, the structure predicted that mutation of Phe129 to serine (F129S) or alanine (F129A) should prevent formation of favorable hydrophobic contacts and potential stacking interactions. In this context F129W is considered a conservative mutation. Importantly, Asn82, Ser84 and Phe129 are located in exposed positions in nectin-1 and we considered it unlikely that their mutation would affect the folding of the receptor.</p>
        <p>To analyze the effects of these mutations on binding of nectin-1 to gD <italic>in vitro</italic>, we produced chimeras comprising the nectin-1 V-domains (aa 31â146) fused at its C-terminus to the maltose binding protein (N1V-MBP). We first analyzed the ability of the N1V-MBP proteins to bind gD by ELISA (<xref ref-type="fig" rid="ppat-1002277-g003">
<bold>Fig. 3A</bold>
</xref>). While S84R and T66Q nectin-1 mutants bound to gD(285t) similarly to wt, S84Y and N82Y mutation markedly decreased binding. Furthermore, the aromatic side chain at Phe129 was critical for gD complex formation as F129S mutation severely compromised gD binding while F129W did not (<xref ref-type="fig" rid="ppat-1002277-g003">
<bold>Fig. 3A</bold>
</xref>).</p>
        <fig id="ppat-1002277-g003" position="float">
          <object-id pub-id-type="doi">10.1371/journal.ppat.1002277.g003</object-id>
          <label>Figure 3</label>
          <caption>
            <title>Effect of nectin-1 mutations on binding to gD.</title>
            <p>
<bold>A</bold>. Binding of purified gD(306t) to immobilized N1V-MBP by ELISA. Dilutions of gD were added to the same amount of immobilized N1V-MBP proteins. Bound gD was detected with polyclonal rabbit serum R8. <bold>B</bold>. Blocking of entry of HSV-1 KOS-tk12 into HeLa cells with soluble N1V-MBP proteins. Virus was preincubated with various concentrations of the indicated purified proteins for 1h and then added to HeLa cells. Entry was monitored 6h post infection by measuring Î²-galactosidase activity. The results are reported as percent of Î²-galactosidase signal compared to infection in the absence of soluble inhibitor (dotted line). A representative experiment is shown. <bold>C</bold>. Antigenic characterization of N1V-MBP mutants by ELISA. The purified wt fusion protein and each mutants were captured by the indicated immobilized anti-nectin-1 Ig and detected with anti-MBP antibody conjugated to HRP. Detection of each mutant is represented as percent of wt detection. An average of at least 5 experiments is shown with standard deviation.</p>
          </caption>
          <graphic xlink:href="ppat.1002277.g003"/>
        </fig>
        <p>We next analyzed the ability of mutant N1V-MBP proteins to interact with gD on virions. We tested whether the purified soluble receptors blocked HSV entry into cells by competing with cell surface nectin-1. We used HeLa cells as targets since soluble nectin-1 V-domain produced in baculovirus efficiently blocked entry in these cells <xref rid="ppat.1002277-Krummenacher5" ref-type="bibr">[30]</xref>. Consistent with the ELISA results, proteins with the mutations F129S or N82Y failed to block entry (<xref ref-type="fig" rid="ppat-1002277-g003">
<bold>Fig. 3B</bold>
</xref>). Mutation S84Y had intermediate blocking activity, which correlated with its reduced binding to gD. The other mutants (F129W, S84R and T66Q), which bound gD like the wt protein by ELISA, retained the ability to block virus entry. These observations indicates that these mutants bind virion gD with sufficient affinity to compete with cell surface nectin-1 for binding to gD on the viral envelope.</p>
      </sec>
      <sec id="s3h">
        <title>Nectin-1 mutations and CK41 MAb binding</title>
        <p>We determined the effects of nectin-1 mutations on binding to the conformation-dependent MAb CK41. This antibody blocks binding of nectin-1 to gD and efficiently prevents nectin-1 usage for HSV entry <xref rid="ppat.1002277-Krummenacher5" ref-type="bibr">[30]</xref>. We therefore anticipated that mutations designed to prevent gD binding would also affect the interaction with CK41. Indeed mutations that affected gD binding (i.e. S84Y, N82Y and F129S) also hindered CK41 binding (<xref ref-type="fig" rid="ppat-1002277-g003">
<bold>Fig. 3C</bold>
</xref>). In addition, since the conserved mutation F129W decreased CK41 recognition by 50%, without affecting gD binding, we infer that Phe129 is likely part of the CK41 epitope. Change of Ser84 to arginine does not affect CK41 detection, while a change to tyrosine decreased binding of this MAb. Overall these data mirror the binding properties of these nectin-1 mutants to gD and are consistent with the prediction that the CK41 epitope involves residues critical for gD binding <xref rid="ppat.1002277-Krummenacher5" ref-type="bibr">[30]</xref>.</p>
      </sec>
      <sec id="s3i">
        <title>Mutations of nectin-1 affect its function as an HSV receptor</title>
        <p>To further assess the functional role of individual residues at the gD/Nectin-1 interface, we tested a subset of mutants in a viral entry assay. Mutations were engineered in full-length nectin-1 and transfected into receptor-negative B78H1 mouse melanoma cells <xref rid="ppat.1002277-Krummenacher6" ref-type="bibr">[32]</xref>. Upon transient expression of wt nectin-1, B78H1 cells become susceptible to HSV entry (<xref ref-type="fig" rid="ppat-1002277-g004">
<bold>Fig. 4A</bold>
</xref>) <xref rid="ppat.1002277-Krummenacher6" ref-type="bibr">[32]</xref>. While all tested mutants allowed some level entry of HSV-1 KOS tk12 in a dose dependent manner, mutants F129S and F129A exhibited a marked decrease in entry compared to wild type (<xref ref-type="fig" rid="ppat-1002277-g004">
<bold>Fig. 4B</bold>
</xref>). These results are consistent with the reduced binding affinity of the mutated receptor to gD. Nectin-1 mutants N82Y and S84Y were only partially reduced in their ability to support HSV entry despite exhibiting profound decrease in N1V-MBP binding to gD by ELISA. Such a discrepancy between binding and entry function has been previously observed <xref rid="ppat.1002277-Struyf1" ref-type="bibr">[47]</xref>, <xref rid="ppat.1002277-Connolly4" ref-type="bibr">[51]</xref>. It is likely that the decrease in affinity observed between the purified proteins is less critical in the context of the cell-virus interaction due to avidity effects (i.e. HSV binding to multiple receptor molecules and to cell surface HS) thus making the entry assays more permissive <xref rid="ppat.1002277-Struyf1" ref-type="bibr">[47]</xref>, <xref rid="ppat.1002277-Connolly4" ref-type="bibr">[51]</xref>. Overall, however, the phenotypes of the mutants agreed with their importance for stabilizing the interface indicated by the structure of the complex.</p>
        <fig id="ppat-1002277-g004" position="float">
          <object-id pub-id-type="doi">10.1371/journal.ppat.1002277.g004</object-id>
          <label>Figure 4</label>
          <caption>
            <title>Effect of nectin-1 mutations on HSV entry. A</title>
            <p>. Receptor negative B78H1 cells were transfected with full-length nectin-1 carrying the indicated mutations. HSV KOS-tk12 virus was added at various MOI. Entry was recorded 6h post infection by measuring Î²-galactosidase activity. A representative experiment is shown. Background signal from mock-transfected cells is also shown. <bold>B</bold>. Summary of all the entry data at an MOI of 5 pfu/cell. Levels of entry into cells expressing nectin-1 mutants are reported as the percentage of entry into B78H1 cells transfected with wt nectin-1. An average of 6 experiments is shown with standard deviation.</p>
          </caption>
          <graphic xlink:href="ppat.1002277.g004"/>
        </fig>
      </sec>
      <sec id="s3j">
        <title>Nectin-1 and HVEM binding sites on gD are mutually exclusive and require the displacement of gD C-terminal region</title>
        <p>Comparison of the gD/Nectin-1 and gD/HVEM structures reveals that the two receptors bind to different but overlapping sites. Although each receptor buries a comparable area on gD, for the most part their binding sites do not involve common residues. In fact, the binding site of HVEM is located exclusively within the first 32 N-terminal residues of gD that are folded in a hairpin-like structure <xref rid="ppat.1002277-Carfi1" ref-type="bibr">[21]</xref>. The same hairpin does not form in the nectin-1 complex, rather the first N-terminal 22 residues of gD point towards the solvent (<xref ref-type="fig" rid="ppat-1002277-g005">
<bold>Fig. 5A</bold>â<bold>D</bold>
</xref>). However, a large portion of the gD surface contacted by nectin-1 would be covered by these N-terminal residues if they were adopting the same hairpin structure observed in the gD/HVEM complex (<xref ref-type="fig" rid="ppat-1002277-g005">
<bold>Fig. 5A</bold>â<bold>D</bold>
</xref>). Thus the structural comparison reveals that nectin-1 and HVEM bind to different sites on gD but the binding of one receptor should prevent the binding of the other.</p>
        <fig id="ppat-1002277-g005" position="float">
          <object-id pub-id-type="doi">10.1371/journal.ppat.1002277.g005</object-id>
          <label>Figure 5</label>
          <caption>
            <title>Unliganded gD and gD/receptor complexes.</title>
            <p>
<bold>A, B</bold>. Surface representation of gD bound to nectin-1, with nectin-1 removed (A) or present (B). Residues 23â38 of gD are colored light green, the V-domain (residues 56â185) is colored yellow and the other residues from N-terminal (residues 39â55) and C-terminal (residues 186â250) extensions are in gray. Residues buried by nectin-1 in the gD/Nectin-1 complex are colored in dark blue. The V domain of nectin-1 is colored violet and the C1 domain is pink. <bold>C, D</bold>. View of gD bound to HVEM with HVEM removed (C) or present (D). Colored as in panel A with the N-terminal region involved in HVEM binding colored in dark green (residues 1 to 16) and in light-green (residues 17â38). Residues 1â16 of gD, which were not localized in the gD/Nectin-1 structure, fold back to form a hairpin structure when HVEM is bound. In the latter conformation, these residues mask the nectin-1 binding site. HVEM is shown in light blue. <bold>E</bold>. Conformation of unliganded gD colored as in panel A with residues 260â306 from the C-terminal extension colored in red.</p>
          </caption>
          <graphic xlink:href="ppat.1002277.g005"/>
        </fig>
        <p>The unliganded gD structure showed the C-terminal residues 268â306 wrapped around the gD core (<xref ref-type="fig" rid="ppat-1002277-g005">
<bold>Fig. 5E</bold>
</xref>) <xref rid="ppat.1002277-Carfi1" ref-type="bibr">[21]</xref>, <xref rid="ppat.1002277-Krummenacher2" ref-type="bibr">[22]</xref>. Notably, in this position, these residues cover a large portion of the nectin-1 binding site (<xref ref-type="fig" rid="ppat-1002277-g005">
<bold>Fig. 5A, B and E</bold>
</xref>). Therefore, formation of the gD/Nectin-1 complex requires disruption of the contacts between the core and the C-terminus of the gD ectodomain <xref rid="ppat.1002277-Krummenacher2" ref-type="bibr">[22]</xref>, <xref rid="ppat.1002277-Lazear1" ref-type="bibr">[52]</xref>. Interestingly, this separation is also required for the formation of the HVEM-binding N-terminal hairpin of gD (<xref ref-type="fig" rid="ppat-1002277-g005">
<bold>Fig. 5C and E</bold>
</xref>) <xref rid="ppat.1002277-Krummenacher2" ref-type="bibr">[22]</xref>.</p>
      </sec>
    </sec>
    <sec id="s4">
      <title>Discussion</title>
      <p>The structure and mutagenesis data reported here provide the molecular basis for the interaction between gD and its cellular receptor human nectin-1. The structure shows the key features of the interface between the nectin-1 V-domain and the core of gD <xref rid="ppat.1002277-Krummenacher4" ref-type="bibr">[28]</xref>. The binding site for gD overlaps with a nectin-1 dimerization interface explaining how gD interferes with the cell-adhesion function of this receptor. In addition, the gD/Nectin-1 complex reveals structural similarities with other viral ligands bound to receptors with an Ig-like fold, thus pointing to a convergent mechanism for receptor selection and usage by otherwise unrelated viruses. Importantly, comparison of the gD/Nectin-1 structure with the previously determined gD/HVEM structure indicates that despite contacting different amino acids the two receptors compete for binding to gD. Finally, a comparison between the two gD-receptor structures and the unliganded gD structure provides additional insights into the mechanism of receptor-mediated activation of the HSV fusion machinery.</p>
      <sec id="s4a">
        <title>The gD/Nectin-1 interface</title>
        <p>The gD/Nectin-1 structure confirms the presence at the interface of a number of gD residues that were previously identified by mutagenesis to be important for nectin-1 usage and HSV entry <xref rid="ppat.1002277-Spear1" ref-type="bibr">[36]</xref>, <xref rid="ppat.1002277-Uchida1" ref-type="bibr">[44]</xref>, <xref rid="ppat.1002277-Connolly3" ref-type="bibr">[46]</xref>, <xref rid="ppat.1002277-Manoj1" ref-type="bibr">[53]</xref>. gD contacts a large surface on the nectin-1 V-domain composed mainly by residues from the Câ³Câ²CFG Î²-sheet. In other cell adhesion molecules of the Ig-superfamily this same region is involved in homophilic and heterophilic trans-interactions and nectin-1 uses the same surface to homo-dimerize <xref rid="ppat.1002277-Narita1" ref-type="bibr">[26]</xref>. Therefore, and in agreement with our SEC/MALS data, formation of the gD/Nectin-1 complex requires dissociation of the nectin-1 dimers. Consistent with these findings, gD can prevent nectin-1 mediated cell aggregation <xref rid="ppat.1002277-Krummenacher6" ref-type="bibr">[32]</xref> and HSV infection is favored by prior disruption of cell junctions <xref rid="ppat.1002277-Yoon2" ref-type="bibr">[54]</xref>.</p>
        <p>Notably, non-enveloped adenovirus, reovirus and measles virus bind to a similar epitope on their respective receptors, the Ig-like cell-adhesion receptors CAR, JAM-A and SLAM (<xref ref-type="fig" rid="ppat-1002277-g006">
<bold>Fig. 6A</bold>â<bold>D</bold>
</xref>) <xref rid="ppat.1002277-Hashiguchi1" ref-type="bibr">[50]</xref>, <xref rid="ppat.1002277-Bergelson1" ref-type="bibr">[55]</xref>, <xref rid="ppat.1002277-Mendelsohn1" ref-type="bibr">[56]</xref>, <xref rid="ppat.1002277-Barton1" ref-type="bibr">[57]</xref>). Similarly to HSV, these viruses disrupt the homophilic trans-interactions of their receptors <xref rid="ppat.1002277-Kirchner1" ref-type="bibr">[41]</xref>, <xref rid="ppat.1002277-vanRaaij1" ref-type="bibr">[49]</xref>. Binding to cell-adhesion molecules may ultimately favor release of these viruses by opening intercellular junctions <xref rid="ppat.1002277-Walters1" ref-type="bibr">[58]</xref>.</p>
        <fig id="ppat-1002277-g006" position="float">
          <object-id pub-id-type="doi">10.1371/journal.ppat.1002277.g006</object-id>
          <label>Figure 6</label>
          <caption>
            <title>Similarities in the interactions between adhesion molecules with Ig-like fold and viral receptor-binding proteins.</title>
            <p>The Ig-like domains of the receptors are shown in similar orientation and colored in red with the region that appears most structurally variable in cyan. <bold>A</bold>. Nectin-1 V-domain bound to HSV gD (gold). <bold>B</bold>. Coxsackie and Adenovirus receptor, CAR, domain D1 bound to Ad12 of adenovirus (blue) (pdb-id 1KAC). <bold>C</bold>. Junctional adhesin molecule-A, JAM-A, domain D1 bound to reovirus Ï1 (green) (pdb-id 3EOY). <bold>D</bold>. Signaling lymphocyte activation molecule, SLAM, bound to measles virus hemagglutinin, MV-H, (purple) (pdb-id 3ALX).</p>
          </caption>
          <graphic xlink:href="ppat.1002277.g006"/>
        </fig>
      </sec>
      <sec id="s4b">
        <title>Contribution of nectin-1 phenylalanine 129 to gD binding</title>
        <p>On the nectin-1 side, point mutations of residues in the Câ³Câ²C region can affect binding to gD (e.g. S84Y, N82Y); however, they have limited effects on nectin-1 as a mediator of HSV entry. This suggests that the interactions established by single amino acids in this region may not be critical for function. Indeed, the same conclusion can be drawn from the gD side where multiple mutations are needed to abolish nectin-1 usage <xref rid="ppat.1002277-Spear1" ref-type="bibr">[36]</xref>, <xref rid="ppat.1002277-Uchida1" ref-type="bibr">[44]</xref>. This is quite different from the role of Phe129 at the tip of the FG loop of the nectin-1 V-domain. Mutations of Phe129 to alanine showed that this residue plays an important role for tight gD binding and for HSV entry. Of note, Phe129 protrudes into a pocket on the gD surface occupied in the unliganded gD by the C-terminal residue Trp294 (<xref ref-type="fig" rid="ppat-1002277-g007">
<bold>Fig. 7</bold>
</xref>). Therefore, nectin-1 Phe129 effectively substitutes for gD Trp294 and provides a key contribution to the stable displacement of the gD C-terminal region.</p>
        <fig id="ppat-1002277-g007" position="float">
          <object-id pub-id-type="doi">10.1371/journal.ppat.1002277.g007</object-id>
          <label>Figure 7</label>
          <caption>
            <title>Functional pocket on the surface of gD.</title>
            <p>Comparison between unliganded gD and gD/Nectin-1 complex. gD N-terminal residues 23â38 are green, the Ig-like V-domain is colored yellow (aa 56â185), the C-terminal region (aa 268â306) is shown in red and the remaining residues are white. <bold>A</bold>. In unliganded gD, the C-terminus of the ectodomain (red) is maintained in place by the insertion of Trp294 into a pocket made of the gD N-terminal residues, the Î±3-helix and residues from the Ig-core. This interaction is critical for function. <bold>B</bold>. The side chain of Phe129 (purple) located on the FG loop of the nectin-1 V-domain protrudes into the same pocket in the complex with gD. This binding configuration is not compatible with the native position of the gD C-terminus.</p>
          </caption>
          <graphic xlink:href="ppat.1002277.g007"/>
        </fig>
        <p>Importantly, Phe129 is conserved in the poliovirus receptor necl-5 and nectin-2, consistent with the finding that a chimera composed of the necl-5 or nectin-2 V-domain where strands Câ³Câ² were replaced with the corresponding residues of nectin-1 retains binding to gD and allows HSV infection <xref rid="ppat.1002277-Cocchi2" ref-type="bibr">[29]</xref>, <xref rid="ppat.1002277-Menotti2" ref-type="bibr">[59]</xref>. The equivalent FG loop in necl-5 has been shown to be at the interface with poliovirus and to be important for poliovirus binding <xref rid="ppat.1002277-Zhang1" ref-type="bibr">[38]</xref>, pointing to a conserved feature in the interaction between HSV and poliovirus with their respective receptors.</p>
      </sec>
      <sec id="s4c">
        <title>Comparison with the gD/HVEM complex and implication for gD activation</title>
        <p>Nectin-1 and HVEM are two gD receptors that belong to different structural families. Consistently, the gD/Nectin-1 complex shares only limited similarity with the gD/HVEM complex <bold>(</bold>
<xref ref-type="fig" rid="ppat-1002277-g005">
<bold>Fig. 5</bold>
</xref>). The binding site of nectin-1 on gD differs dramatically from that of HVEM. The latter contacts only residues within the first N-terminal 32 residues of gD folded in a hairpin-like structure and the interaction involves several hydrogen bonds through main and side chain atoms <xref rid="ppat.1002277-Carfi1" ref-type="bibr">[21]</xref>. The nectin-1 V-domain, instead, contacts a large surface on gD formed mostly by residues from the C-terminal extension and some amino acids from the N-terminal region. However, structural superposition of the two gD-receptor structures reveals that most of the residues involved in nectin-1 binding are buried by the gD-N-terminal residues in the gD/HVEM complex (<xref ref-type="fig" rid="ppat-1002277-g005">
<bold>Fig. 5</bold>
</xref>). Thus, despite their considerably different binding sites, each receptor is likely to interfere with binding of the other. Indeed soluble nectin-1 can block virus entry in HVEM expressing cells <xref rid="ppat.1002277-Geraghty2" ref-type="bibr">[60]</xref>.</p>
        <p>A comparison between the gD-receptor complexes and the structure of unliganded gD provides additional insights in the mechanism of receptor-mediated activation of gD. In the absence of receptors residues from the gD C-terminal region (residues 285â306) are anchored by Trp294 on the core of gD. In this conformation, the C-terminus of gD occludes the nectin-1 binding site and fills the space occupied by gD N-terminal residues in the gD/HVEM complex. This is consistent with the increase receptor affinity of the C-terminally truncated form of gD used in this study compared to the full length molecule <xref rid="ppat.1002277-Krummenacher3" ref-type="bibr">[25]</xref>, <xref rid="ppat.1002277-Willis1" ref-type="bibr">[61]</xref>. Therefore, for both receptors complex formation requires the displacement of residues from the gD C-terminal region.</p>
      </sec>
      <sec id="s4d">
        <title>Role of the C-terminus of the gD ectodomain</title>
        <p>During HSV entry, gD interacts with gH/gL and possibly gB <xref rid="ppat.1002277-Atanasiu1" ref-type="bibr">[4]</xref>, <xref rid="ppat.1002277-Gianni1" ref-type="bibr">[62]</xref>, <xref rid="ppat.1002277-PerezRomero1" ref-type="bibr">[63]</xref> but how gD triggers conformational changes in the other glycoproteins remains unclear. Several observations point to a key role of the gD C-terminal region. A soluble gD molecule encompassing the entire ectodomain allows entry of a gDnull virus (i.e. devoid of envelope gD) in receptor expressing cells, whereas a truncated form of gD lacking residues 260â316 does not <xref rid="ppat.1002277-Cocchi3" ref-type="bibr">[64]</xref>. Moreover, mutagenesis data showed that the C-terminal region is essential for virus entry <xref rid="ppat.1002277-Lazear1" ref-type="bibr">[52]</xref>, <xref rid="ppat.1002277-Gianni1" ref-type="bibr">[62]</xref>, <xref rid="ppat.1002277-Cocchi3" ref-type="bibr">[64]</xref>, <xref rid="ppat.1002277-Zhou1" ref-type="bibr">[65]</xref>, <xref rid="ppat.1002277-Zago1" ref-type="bibr">[66]</xref>. These data support a role for the gD C-terminal region in activation of the fusion/entry process. They also suggest a critical role for this region for the interaction with other viral glycoproteins. Exposure of the C-terminal region upon receptor binding therefore provides a timely and cell specific trigger for the activation of the HSV entry process. The conformation of the C-terminus in receptor-bound gD has not been determined due to its high flexibility.</p>
        <p>Remarkably, gD has been engineered to bind alternate receptors <xref rid="ppat.1002277-Zhou2" ref-type="bibr">[67]</xref>, <xref rid="ppat.1002277-Kamiyama1" ref-type="bibr">[68]</xref>, <xref rid="ppat.1002277-Menotti3" ref-type="bibr">[69]</xref>, <xref rid="ppat.1002277-Menotti4" ref-type="bibr">[70]</xref>. Heterologous ligands such as uPA, IL13, and a single chain antibody to HER-2 were engineered in at least three different regions in the gD-N-terminus or replaced the entire gD Ig core. All these ligands are able to mediate entry of HSV virions carrying the chimeric forms of gD in cells expressing the respective receptors. In the absence of structural data on such chimeras, one can only speculate on their mechanism of action during entry. Even in the most extreme recombinant <xref rid="ppat.1002277-Menotti4" ref-type="bibr">[70]</xref>, the N-terminal and C-terminal extensions to the Ig core are maintained for activity <xref rid="ppat.1002277-Zhou3" ref-type="bibr">[71]</xref>. Thus, these regions likely contain the necessary sites for binding and activation of the other viral glycoproteins. In the engineered gDs the C-terminus may be exposed upon exogenous receptor binding in a way that is very similar to the model supported by our studies for wt HSV. Alternatively, this functional region may already be exposed in these molecules so that exogenous receptor binding would solely allow the close proximity of viral and cell membranes. In such a situation, expressing a pre-activated gD may lead to a decrease in viral fitness by diminishing the selectivity for target cells. It is likely that HSV evolved to unmask the gD C-terminus only upon receptor binding to ensure efficient tropism in the host. Of note, the initial analysis of the structural organization of gD revealed that the Ig-core acts as structural support to the functional C- and N- terminal regions and suggested that it inserted in an ancestor molecule formed by the N- and C- terminal extensions <xref rid="ppat.1002277-Carfi1" ref-type="bibr">[21]</xref>. The results obtained with the above engineered gDs are consistent with such hypothesis.</p>
        <p>In summary, our data reveal the molecular basis for the gD/Nectin-1 interaction. This new structure shows how nectin-1 and HVEM, albeit belonging to different structural families and establishing different interactions with gD, similarly cause the disruption of intra-molecular contacts between the gD C-terminal region and the rest of the molecule thus leading to activation of the entry process through a conserved mechanism. The structure of the gD/Nectin-1 complex also provides a frame to design of inhibitors that would block HSV entry and infection.</p>
      </sec>
    </sec>
    <sec sec-type="materials|methods" id="s5">
      <title>Materials and Methods</title>
      <sec id="s5a">
        <title>Complex purification</title>
        <p>Production of gD-1 KOS (residues 1 to 285, gD(285t)) and human nectin-1 (residues 31â346, gD(346t)) using recombinant baculoviruses and their purification were described previously <xref rid="ppat.1002277-Carfi1" ref-type="bibr">[21]</xref>, <xref rid="ppat.1002277-Krummenacher3" ref-type="bibr">[25]</xref>. The complex used for crystallization experiments was formed by mixing purified gD and nectin-1 in a 1.3â¶1 molar ratio. Unbound gD in excess was removed by size exclusion chromatography (SEC) on a analytical Superdex-200 column in 20mM TRIS-HCl pH 8.0 buffer and 300mM NaCl. The complex, which eluted as single peak from the SEC step, was concentrated to 3.5mg/ml and stored at 4Â°C prior to crystallization.</p>
      </sec>
      <sec id="s5b">
        <title>Crystallization and data processing</title>
        <p>The gD/Nectin-1 complex was crystallized by the vapor diffusion method with 1.0M Na<sub>2</sub>HPO<sub>4</sub>/KH<sub>2</sub>PO<sub>4</sub> pH 7.2 and 300mM NH<sub>4</sub>SO<sub>4</sub> as precipitating agents. SDS gels and N-terminal sequencing on washed crystals confirmed the presence of the full-sized proteins. The crystals had a very low reproducibility, suffered from strong anisotropy and the great majority diffracted only up to 7â8 Ã resolution at different x-ray synchrotron sources. Nevertheless, after screening more than 100 crystals a 4.0 Ã data set was collected at the BM14 beam line at the Advanced Photon Source (APS), Argonne National Lab. (<bold><xref ref-type="supplementary-material" rid="ppat.1002277.s004">Table S1</xref></bold>). The HKL suite was used for data integration and scaling <xref rid="ppat.1002277-Otwinowski1" ref-type="bibr">[72]</xref> and the CCP4 suite was used for further data processing and analysis <xref rid="ppat.1002277-CCP41" ref-type="bibr">[73]</xref>.</p>
        <p>Data integration suggested that the crystals belong to the hexagonal P6<sub>2</sub>22 space group, however analysis of the cumulative intensity distribution <xref rid="ppat.1002277-CCP41" ref-type="bibr">[73]</xref> hinted at the presence of merohedral twinning and as a consequence to a lower symmetry space group. Data analysis with the Merohedral Crystal Twinning server for data integrated in P321 or P312 pointed to the presence of nearly perfect merohedral twinning (Î±â=â0.49) <xref rid="ppat.1002277-Yeates1" ref-type="bibr">[74]</xref>. Due to the difficulty of obtaining similar quality diffraction this data set was used for subsequent structure determination and refinement despite integration in the trigonal space groups resulted in low redundancy (<bold><xref ref-type="supplementary-material" rid="ppat.1002277.s004">Table S1</xref></bold>).</p>
      </sec>
      <sec id="s5c">
        <title>Structure determination and refinement</title>
        <p>The structure was determined by the Molecular Replacement (MR) method with the program Phaser <xref rid="ppat.1002277-McCoy1" ref-type="bibr">[34]</xref>. The initial search was carried out in all trigonal and hexagonal space groups with a gD model (PDB entry 2C36: amino acids 27â250) and using all data between 12 and 4.0Ã. A clear solution for 3 gD molecules was identified in P3<sub>2</sub>21 whereas no solutions were found in all the other space groups tested. A polyalanine version of the major structural protein of peripheral nerve myelin (1NEU; 27% sequence identity with the V-domain of nectin-1), the C1 domain of the poliovirus receptor neclâ5/CD155 (3EOW; 34% identity with the C1 domain of nectin-1) and the perlecan IG3 domain (1GL4 25% identity), after removal of some of the loops, were used as search models for the V, C1 and C2 domains of the receptor, respectively. Keeping the 3 gD molecules fixed, three solutions for the V domain and then for the C1 domains of nectin-1, consistent with 3 gD-nectin-1 complexes in the asymmetric unit, were clearly identified. In addition to the improvements in TFZ, LLG, R<sub>work</sub> and R<sub>free</sub> during all the steps of MR several pieces of evidence supported the correctness of the solution. First, the nectin-1 V-domain was positioned in proximity of gD residues previously implicated in nectin-1 binding; second, the N- and C-termini of the C1 and V-domain, respectively, were at a distance from each other compatible with the number of missing residues connecting the two domains; and third the model agreed with considerations on packing and symmetry relation between the molecules in the crystal (see also <xref ref-type="sec" rid="s3">Results</xref>). However, only a poorly contrasted solution for one of the C2 domains could be identified by MR. Despite this solution positioned the C2 domain in proximity of a C1 domain with reasonable crystal contacts, its addition to the model did not improve the R<italic><sub>free</sub></italic> or the quality of the electron density maps and therefore was excluded from the refinement.</p>
        <p>Simulated annealing composite 2mFo-DFc and mFo-DFc omit electron density maps followed by local three fold NCS averaging for each of the nectin-1 domains were calculated with the program Phenix <xref rid="ppat.1002277-Adams1" ref-type="bibr">[75]</xref> and used during the initial stages of model building. The resulting electron density maps clearly revealed the location of some of the loops in the nectin-1 V-domain and some of the glycans both of which had been excluded from the MR model (<bold><xref ref-type="supplementary-material" rid="ppat.1002277.s001">Fig. S1</xref></bold>). The electron density of the glycans and of residues with large side chains together with the location of disulfide bonds in V and C1 Ig domains were used to confirm the register of the polypeptide chain. The model was refined with Refmac using the â³detwinâ³ option, overall B-factor refinement and tight non-crystallographic symmetry (NCS) restraints. The twinning fraction estimated by Refmac was of 0.49, in agreement with what reported by the Merohedral Crystal Twinning Server. When the structure was refined without allowing for detwinning of the data the R<sub>free</sub> was â¼10% higher. Following the initial building the crystal structure of nectin-1 became available <xref rid="ppat.1002277-Narita1" ref-type="bibr">[26]</xref> and was used to modify the V and C1 domains. Additional refinement showed that although most of the structure remained the same between the two models, modest differences were present in between the structures in some of the V1 loops and residues involved in the gD-nectin-1 interface. The final model includes the full V1 domain but does not include some of the loops in the distal part of the nectin-1 C1 domain which did not have interpretable electron density.</p>
      </sec>
      <sec id="s5d">
        <title>Production of nectin-1 V-domain-MBP</title>
        <p>A DNA fragment corresponding to the variable immunoglobulin domain (V-type) of nectin-1 was amplified by PCR from a plasmid containing the cDNA form of the full length protein (pCK451) <xref rid="ppat.1002277-Krummenacher7" ref-type="bibr">[76]</xref>, using primers designed to insert a stop codon after residue 146. This fragment was inserted into the bacterial gene fusion vector pMAL-p (New England Biolabs) by a blunt-ended ligation into BamH1 restriction site of the plasmid polylinker. This construct produces a fusion with the maltose-binding protein under the control of the Lac repressor that is exported to the periplasm. Mutants were produced using the Quikchange mutagenesis kit (Stratagene). Correctness of all the constructs was verified by sequencing. For protein purification, E. coli BL21 (DE3*) cells were transformed with the constructs, grown at 37Â°C in LB to an optical density of 0.7 at 600nm and induced with ITPG for 16 h at 23Â°C. After an overnight culture cells were resuspended in 40mM TRIS pH 7.5, 300mM NaCl, 10% glycerol, 0.03% Î²-octyl-glucoside (Buffer A, 100ml/liter of culture) and lysed with a microfluidizer. Debris were removed by centrifugation (13000 rpm) for 45 min at 4Â°C and the supernatant was incubated with amylose resin (New England Biolabs). After binding, the resin was washed with Buffer A and proteins were eluted with 20mM maltose in Buffer A. Proteins were concentrated and purified by size exclusion chromatography on a Superdex S200 column equilibrated with 40mM Tris pH 8.0 and 150mM NaCl. Fractions containing non-aggregated nectin-1 V-domain MBP fusion protein (N1V-MBP) were pooled, concentrated and dialyzed against PBS. All the N1V-MBP mutants were purified similarly to the wild type protein.</p>
      </sec>
      <sec id="s5e">
        <title>Nectin-1 mutants and gD binding</title>
        <p>Purified N1V-MBP fusion proteins were immobilized on a 96 well plate (10 Âµg/ml in PBS) overnight at 4Â°C. Plates were blocked with PBS containing 0.05%, Tween20 and 5% nonfat milk (PBS-T milk). Purified gD(306t) (residues 1 to 306) was serially diluted in PBS-T milk and added to the plate <xref rid="ppat.1002277-Krummenacher3" ref-type="bibr">[25]</xref>. After incubation and washing with PBS-T, bound gD was detected with polyclonal rabbit serum R8 (diluted 1â¶500 in PBS-T-milk) and goat anti-rabbit-HRP secondary antibody (KPL Inc). Absorbance at 405 nm was read after addition of ABTS as substrate.</p>
      </sec>
      <sec id="s5f">
        <title>Blocking HSV infection</title>
        <p>HSV-1 KOStk12 <xref rid="ppat.1002277-Montgomery1" ref-type="bibr">[9]</xref> was diluted in cell culture medium and pre-incubated with purified N1V-MBP proteins at various concentrations for 1 h at 37Â°C. The mixture was added to confluent HeLa cell cultures in a 96 well plate (5Ã10<sup>4</sup> cells/well) and directly incubated at 37Â°C for 5â6 h. Lysis and reading of Î²-galactosidase activity was performed as described below for entry assays.</p>
      </sec>
      <sec id="s5g">
        <title>CK41 detection by ELISA</title>
        <p>Purified anti-nectin-1 monoclonal antibody CK41 <xref rid="ppat.1002277-Krummenacher5" ref-type="bibr">[30]</xref> was immobilized on an ELISA plate in PBS (10 Âµg/ml). After blocking with PBS-T-milk, purified N1V-MBP (20 Âµg/ml) was added in PBS-T-milk for 2 h at RT. The wells were washed and N1V-MBP was detected with HRP-conjugated anti-MBP antibody MBP-17 (Sigma-Aldrich), followed by goat anti-rabbit-HRP secondary antibody (KPL Inc). Absorbance at 405 nm was read after addition of ABTS as substrate.</p>
      </sec>
      <sec id="s5h">
        <title>Nectin-1 mutants and HSV entry</title>
        <p>Mutations were engineered in full-length nectin-1 using the Quikchange mutagenesis kit in plasmid pCK452 expressing full-length human nectin-1Î± <xref rid="ppat.1002277-Krummenacher7" ref-type="bibr">[76]</xref>. Plasmids were transfected into B78H1 cells using either Geneporter (2 Âµg plasmid/ well of subconfluent cells in 6 well plates) or the AMAXA system kit V, 2 Âµg/10<sup>6</sup> cells. One day post transfection cells were seeded in 96 well plates (5Ã10<sup>4</sup> cells/well). After an overnight culture, cells were infected with dilutions of sucrose-purified HSV-1 KOS tk12. After 6 h incubation at 37Â°C cells were lysed by adding NP-40 to a final concentration of 0.5%. A 50 Âµl volume of lysate was mixed with an equal volume of Î²-galactosidase substrate (chlorophenol red-Î²-D-galactopyranoside; Roche) and absorbance was read at 595nm for 50 min to record enzymatic activity. Surface expression of nectin-1 mutants was assessed by CELISA using MAb CK6 <xref rid="ppat.1002277-Krummenacher5" ref-type="bibr">[30]</xref> and was comparable between mutants and wt nectin-1 in transiently transfected B78H1 cells.</p>
      </sec>
      <sec id="s5i">
        <title>Accession number for genes and proteins mentioned in the text</title>
        <p>
<italic>Nectin-1</italic>
</p>
        <p>Swissprot/UniProt: Q15223</p>
        <p>NCBI: NP_002846</p>
        <p>
<italic>HVEM</italic>
</p>
        <p>Swissprot/UniProt: Q92956</p>
        <p>NCBI: AAQ89238</p>
        <p>
<italic>gD KOS</italic>
</p>
        <p>Swissprot/UniProt: A1Z0Q5</p>
      </sec>
    </sec>
    <sec sec-type="supplementary-material" id="s6">
      <title>Supporting Information</title>
      <supplementary-material content-type="local-data" id="ppat.1002277.s001">
        <label>Figure S1</label>
        <caption>
          <p>Representative electron density (gray) from a three-fold averaged composite anneal omit map of the nectin-1 V-domain. A region of the final model is shown in the density in stick representation highlighting the presence of two glycosylation sites.</p>
          <p>(TIF)</p>
        </caption>
        <media xlink:href="ppat.1002277.s001.tif">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="ppat.1002277.s002">
        <label>Figure S2</label>
        <caption>
          <p>View of a crystallographic dimer of gD/Nectin-1. gD is shown in yellow and orange and nectin-1 is shown in purple and pink.</p>
          <p>(TIF)</p>
        </caption>
        <media xlink:href="ppat.1002277.s002.tif">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="ppat.1002277.s003">
        <label>Figure S3</label>
        <caption>
          <p>Comparison of the elbow angle of necl-5 (cyan) and nectin-1 (purple). An approximate difference of 15 degrees exists between the two structures. Loops not built in the nectin-1 model are shown as a dotted line.</p>
          <p>(TIF)</p>
        </caption>
        <media xlink:href="ppat.1002277.s003.tif">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="ppat.1002277.s004">
        <label>Table S1</label>
        <caption>
          <p>Data collection and refinement statistics.</p>
          <p>(DOC)</p>
        </caption>
        <media xlink:href="ppat.1002277.s004.doc">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack>
      <p>We are grateful to Patricia G. Spear for the HSV-1 KOStk12 virus. We appreciate the advice and helpful discussions from members of the Krummenacher, Cohen/Eisenberg and CarfÃ­ laboratories.</p>
    </ack>
    <fn-group>
      <fn fn-type="COI-statement">
        <p>The authors have declared that no competing interests exist.</p>
      </fn>
      <fn fn-type="financial-disclosure">
        <p>This investigation was supported by the following Public Health Service grant from the National Institute of Allergy and Infectious Diseases: AI-073384 to C. K., AI-056045 and AI-076231 to R.J.E., and R37-AI-18289 to G.H.C. Also, C.K. was supported by the Joseph and Josephine Rabinowitz award for Research Excellence at the UPENN School of Dental Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="ppat.1002277-Heldwein1">
        <label>1</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Heldwein</surname><given-names>EE</given-names></name><name><surname>Krummenacher</surname><given-names>C</given-names></name></person-group>
<year>2008</year>
<article-title>Entry of herpesviruses into mammalian cells.</article-title>
<source>Cell Mol Life Sci</source>
<volume>65</volume>
<fpage>1653</fpage>
<lpage>1668</lpage>
<pub-id pub-id-type="pmid">18351291</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Connolly1">
        <label>2</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Connolly</surname><given-names>SA</given-names></name><name><surname>Jackson</surname><given-names>JO</given-names></name><name><surname>Jardetzky</surname><given-names>TS</given-names></name><name><surname>Longnecker</surname><given-names>R</given-names></name></person-group>
<year>2011</year>
<article-title>Fusing structure and function: a structural view of the herpesvirus entry machinery.</article-title>
<source>Nat Rev Microbiol</source>
<volume>9</volume>
<fpage>369</fpage>
<lpage>381</lpage>
<pub-id pub-id-type="pmid">21478902</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Eisenberg1">
        <label>3</label>
        <element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Eisenberg</surname><given-names>RJ</given-names></name><name><surname>Heldwein</surname><given-names>EE</given-names></name><name><surname>Cohen</surname><given-names>GH</given-names></name><name><surname>Krummenacher</surname><given-names>C</given-names></name></person-group>
<year>2011</year>
<article-title>Recent progress in understanding herpes simplex virus entry: relationship of structure to function.</article-title>
<person-group person-group-type="editor"><name><surname>Weller</surname><given-names>SK</given-names></name></person-group>
<source>Alphaherpesviruses: Molecular and cellular Biology</source>
<publisher-loc>Norwich, UK</publisher-loc>
<publisher-name>Horizon Scientific Press</publisher-name>
<fpage>131</fpage>
<lpage>152</lpage>
</element-citation>
      </ref>
      <ref id="ppat.1002277-Atanasiu1">
        <label>4</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Atanasiu</surname><given-names>D</given-names></name><name><surname>Saw</surname><given-names>WT</given-names></name><name><surname>Cohen</surname><given-names>GH</given-names></name><name><surname>Eisenberg</surname><given-names>RJ</given-names></name></person-group>
<year>2010</year>
<article-title>Cascade of events governing cell-cell fusion induced by herpes simplex virus glycoproteins gD, gH/gL, and gB.</article-title>
<source>J Virol</source>
<volume>84</volume>
<fpage>12292</fpage>
<lpage>12299</lpage>
<pub-id pub-id-type="pmid">20861251</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Chowdary1">
        <label>5</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chowdary</surname><given-names>TK</given-names></name><name><surname>Cairns</surname><given-names>TM</given-names></name><name><surname>Atanasiu</surname><given-names>D</given-names></name><name><surname>Cohen</surname><given-names>GH</given-names></name><name><surname>Eisenberg</surname><given-names>RJ</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>Crystal structure of the conserved herpesvirus fusion regulator complex gH-gL.</article-title>
<source>Nat Struct Mol Biol</source>
<volume>17</volume>
<fpage>882</fpage>
<lpage>888</lpage>
<pub-id pub-id-type="pmid">20601960</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Milne1">
        <label>6</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Milne</surname><given-names>RS</given-names></name><name><surname>Nicola</surname><given-names>AV</given-names></name><name><surname>Whitbeck</surname><given-names>JC</given-names></name><name><surname>Eisenberg</surname><given-names>RJ</given-names></name><name><surname>Cohen</surname><given-names>GH</given-names></name></person-group>
<year>2005</year>
<article-title>Glycoprotein D receptor-dependent, low-pH-independent endocytic entry of herpes simplex virus type 1.</article-title>
<source>J Virol</source>
<volume>79</volume>
<fpage>6655</fpage>
<lpage>6663</lpage>
<pub-id pub-id-type="pmid">15890903</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Nicola1">
        <label>7</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nicola</surname><given-names>AV</given-names></name><name><surname>Hou</surname><given-names>J</given-names></name><name><surname>Major</surname><given-names>EO</given-names></name><name><surname>Straus</surname><given-names>SE</given-names></name></person-group>
<year>2005</year>
<article-title>Herpes simplex virus type 1 enters human epidermal keratinocytes, but not neurons, via a pH-dependent endocytic pathway.</article-title>
<source>J Virol</source>
<volume>79</volume>
<fpage>7609</fpage>
<lpage>7616</lpage>
<pub-id pub-id-type="pmid">15919913</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Nicola2">
        <label>8</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nicola</surname><given-names>AV</given-names></name><name><surname>Straus</surname><given-names>SE</given-names></name></person-group>
<year>2004</year>
<article-title>Cellular and viral requirements for rapid endocytic entry of herpes simplex virus.</article-title>
<source>J Virol</source>
<volume>78</volume>
<fpage>7508</fpage>
<lpage>7517</lpage>
<pub-id pub-id-type="pmid">15220424</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Montgomery1">
        <label>9</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Montgomery</surname><given-names>RI</given-names></name><name><surname>Warner</surname><given-names>MS</given-names></name><name><surname>Lum</surname><given-names>BJ</given-names></name><name><surname>Spear</surname><given-names>PG</given-names></name></person-group>
<year>1996</year>
<article-title>Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family.</article-title>
<source>Cell</source>
<volume>87</volume>
<fpage>427</fpage>
<lpage>436</lpage>
<pub-id pub-id-type="pmid">8898196</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Tiwari1">
        <label>10</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tiwari</surname><given-names>V</given-names></name><name><surname>Clement</surname><given-names>C</given-names></name><name><surname>Scanlan</surname><given-names>PM</given-names></name><name><surname>Kowlessur</surname><given-names>D</given-names></name><name><surname>Yue</surname><given-names>BY</given-names></name><etal/></person-group>
<year>2005</year>
<article-title>A role for herpesvirus entry mediator as the receptor for herpes simplex virus 1 entry into primary human trabecular meshwork cells.</article-title>
<source>J Virol</source>
<volume>79</volume>
<fpage>13173</fpage>
<lpage>13179</lpage>
<pub-id pub-id-type="pmid">16189018</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Akhtar1">
        <label>11</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Akhtar</surname><given-names>J</given-names></name><name><surname>Tiwari</surname><given-names>V</given-names></name><name><surname>Oh</surname><given-names>MJ</given-names></name><name><surname>Kovacs</surname><given-names>M</given-names></name><name><surname>Jani</surname><given-names>A</given-names></name><etal/></person-group>
<year>2008</year>
<article-title>HVEM and Nectin-1 are the Major Mediators of Herpes Simplex Virus 1 (HSV-1) Entry into Human Conjunctival Epithelium.</article-title>
<source>Invest Ophthalmol Vis Sci</source>
<volume>49</volume>
<fpage>4026</fpage>
<lpage>4035</lpage>
<pub-id pub-id-type="pmid">18502984</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Krummenacher1">
        <label>12</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Krummenacher</surname><given-names>C</given-names></name><name><surname>Baribaud</surname><given-names>F</given-names></name><name><surname>Ponce De Leon</surname><given-names>M</given-names></name><name><surname>Baribaud</surname><given-names>I</given-names></name><name><surname>Whitbeck</surname><given-names>JC</given-names></name><etal/></person-group>
<year>2004</year>
<article-title>Comparative usage of herpesvirus entry mediator A and nectin-1 by laboratory strains and clinical isolates of herpes simplex virus.</article-title>
<source>Virology</source>
<volume>322</volume>
<fpage>286</fpage>
<lpage>299</lpage>
<pub-id pub-id-type="pmid">15110526</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Simpson1">
        <label>13</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Simpson</surname><given-names>SA</given-names></name><name><surname>Manchak</surname><given-names>MD</given-names></name><name><surname>Hager</surname><given-names>EJ</given-names></name><name><surname>Krummenacher</surname><given-names>C</given-names></name><name><surname>Whitbeck</surname><given-names>JC</given-names></name><etal/></person-group>
<year>2005</year>
<article-title>Nectin-1/HveC Mediates herpes simplex virus type 1 entry into primary human sensory neurons and fibroblasts.</article-title>
<source>J Neurovirol</source>
<volume>11</volume>
<fpage>208</fpage>
<lpage>218</lpage>
<pub-id pub-id-type="pmid">16036799</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Galen1">
        <label>14</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Galen</surname><given-names>B</given-names></name><name><surname>Cheshenko</surname><given-names>N</given-names></name><name><surname>Tuyama</surname><given-names>A</given-names></name><name><surname>Ramratnam</surname><given-names>B</given-names></name><name><surname>Herold</surname><given-names>BC</given-names></name></person-group>
<year>2006</year>
<article-title>Access to nectin favors herpes simplex virus infection at the apical surface of polarized human epithelial cells.</article-title>
<source>J Virol</source>
<volume>80</volume>
<fpage>12209</fpage>
<lpage>12218</lpage>
<pub-id pub-id-type="pmid">17005657</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Huber1">
        <label>15</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huber</surname><given-names>MT</given-names></name><name><surname>Wisner</surname><given-names>TW</given-names></name><name><surname>Hegde</surname><given-names>NR</given-names></name><name><surname>Goldsmith</surname><given-names>KA</given-names></name><name><surname>Rauch</surname><given-names>DA</given-names></name><etal/></person-group>
<year>2001</year>
<article-title>Herpes Simplex Virus with Highly Reduced gD Levels Can Efficiently Enter and Spread between Human Keratinocytes.</article-title>
<source>J Virol</source>
<volume>75</volume>
<fpage>10309</fpage>
<lpage>10318</lpage>
<pub-id pub-id-type="pmid">11581399</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Tiwari2">
        <label>16</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tiwari</surname><given-names>V</given-names></name><name><surname>Clement</surname><given-names>C</given-names></name><name><surname>Xu</surname><given-names>D</given-names></name><name><surname>Valyi-Nagy</surname><given-names>T</given-names></name><name><surname>Yue</surname><given-names>BY</given-names></name><etal/></person-group>
<year>2006</year>
<article-title>Role for 3-o-sulfated heparan sulfate as the receptor for herpes simplex virus type 1 entry into primary human corneal fibroblasts.</article-title>
<source>J Virol Methods</source>
<volume>80</volume>
<fpage>8970</fpage>
<lpage>8980</lpage>
</element-citation>
      </ref>
      <ref id="ppat.1002277-Delboy1">
        <label>17</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Delboy</surname><given-names>MG</given-names></name><name><surname>Patterson</surname><given-names>JL</given-names></name><name><surname>Hollander</surname><given-names>AM</given-names></name><name><surname>Nicola</surname><given-names>AV</given-names></name></person-group>
<year>2006</year>
<article-title>Nectin-2-mediated entry of a syncytial strain of herpes simplex virus via pH-independent fusion with the plasma membrane of Chinese hamster ovary cells.</article-title>
<source>Virol J</source>
<volume>3</volume>
<fpage>105</fpage>
<pub-id pub-id-type="pmid">17192179</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Stiles1">
        <label>18</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stiles</surname><given-names>KM</given-names></name><name><surname>Milne</surname><given-names>RS</given-names></name><name><surname>Cohen</surname><given-names>GH</given-names></name><name><surname>Eisenberg</surname><given-names>RJ</given-names></name><name><surname>Krummenacher</surname><given-names>C</given-names></name></person-group>
<year>2008</year>
<article-title>The herpes simplex virus receptor nectin-1 is down-regulated after trans-interaction with glycoprotein D.</article-title>
<source>Virology</source>
<volume>373</volume>
<fpage>98</fpage>
<lpage>111</lpage>
<pub-id pub-id-type="pmid">18076965</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Stiles2">
        <label>19</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stiles</surname><given-names>KM</given-names></name><name><surname>Krummenacher</surname><given-names>C</given-names></name></person-group>
<year>2010</year>
<article-title>Glycoprotein D actively induces rapid internalization of two nectin-1 isoforms during herpes simplex virus entry.</article-title>
<source>Virology</source>
<volume>399</volume>
<fpage>109</fpage>
<lpage>119</lpage>
<pub-id pub-id-type="pmid">20089288</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Stiles3">
        <label>20</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stiles</surname><given-names>KM</given-names></name><name><surname>Whitbeck</surname><given-names>JC</given-names></name><name><surname>Lou</surname><given-names>H</given-names></name><name><surname>Cohen</surname><given-names>GH</given-names></name><name><surname>Eisenberg</surname><given-names>RJ</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>Herpes simplex virus glycoprotein D interferes with binding of herpesvirus entry mediator to its ligands through downregulation and direct competition.</article-title>
<source>J Virol</source>
<volume>84</volume>
<fpage>11646</fpage>
<lpage>11660</lpage>
<pub-id pub-id-type="pmid">20826693</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Carfi1">
        <label>21</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Carfi</surname><given-names>A</given-names></name><name><surname>Willis</surname><given-names>SH</given-names></name><name><surname>Whitbeck</surname><given-names>JC</given-names></name><name><surname>Krummenacher</surname><given-names>C</given-names></name><name><surname>Cohen</surname><given-names>GH</given-names></name><etal/></person-group>
<year>2001</year>
<article-title>Herpes simplex virus glycoprotein D bound to the human receptor HveA.</article-title>
<source>Mol Cell</source>
<volume>8</volume>
<fpage>169</fpage>
<lpage>179</lpage>
<pub-id pub-id-type="pmid">11511370</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Krummenacher2">
        <label>22</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Krummenacher</surname><given-names>C</given-names></name><name><surname>Supekar</surname><given-names>VM</given-names></name><name><surname>Whitbeck</surname><given-names>JC</given-names></name><name><surname>Lazear</surname><given-names>E</given-names></name><name><surname>Connolly</surname><given-names>SA</given-names></name><etal/></person-group>
<year>2005</year>
<article-title>Structure of unliganded HSV gD reveals a mechanism for receptor-mediated activation of virus entry.</article-title>
<source>EMBO J</source>
<volume>24</volume>
<fpage>4144</fpage>
<lpage>4153</lpage>
<pub-id pub-id-type="pmid">16292345</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Connolly2">
        <label>23</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Connolly</surname><given-names>SA</given-names></name><name><surname>Landsburg</surname><given-names>DJ</given-names></name><name><surname>Carfi</surname><given-names>A</given-names></name><name><surname>Wiley</surname><given-names>DC</given-names></name><name><surname>Cohen</surname><given-names>GH</given-names></name><etal/></person-group>
<year>2003</year>
<article-title>Structure-based mutagenesis of herpes simplex virus glycoprotein D defines three critical regions at the gD/HveA interface.</article-title>
<source>J Virol</source>
<volume>77</volume>
<fpage>8127</fpage>
<lpage>8140</lpage>
<pub-id pub-id-type="pmid">12829851</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Yoon1">
        <label>24</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yoon</surname><given-names>M</given-names></name><name><surname>Zago</surname><given-names>A</given-names></name><name><surname>Shukla</surname><given-names>D</given-names></name><name><surname>Spear</surname><given-names>PG</given-names></name></person-group>
<year>2003</year>
<article-title>Mutations in the N termini of herpes simplex virus type 1 and 2 gDs alter functional interactions with the entry/fusion receptors HVEM, Nectin-2, and 3-O-sulfated heparan sulfate but not with Nectin-1.</article-title>
<source>J Virol</source>
<volume>77</volume>
<fpage>9221</fpage>
<lpage>9231</lpage>
<pub-id pub-id-type="pmid">12915538</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Krummenacher3">
        <label>25</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Krummenacher</surname><given-names>C</given-names></name><name><surname>Nicola</surname><given-names>AV</given-names></name><name><surname>Whitbeck</surname><given-names>JC</given-names></name><name><surname>Lou</surname><given-names>H</given-names></name><name><surname>Hou</surname><given-names>W</given-names></name><etal/></person-group>
<year>1998</year>
<article-title>Herpes simplex virus glycoprotein D can bind to poliovirus receptor-related protein 1 or herpesvirus entry mediator, two structurally unrelated mediators of virus entry.</article-title>
<source>J Virol</source>
<volume>72</volume>
<fpage>7064</fpage>
<lpage>7074</lpage>
<pub-id pub-id-type="pmid">9696799</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Narita1">
        <label>26</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Narita</surname><given-names>H</given-names></name><name><surname>Yamamoto</surname><given-names>Y</given-names></name><name><surname>Suzuki</surname><given-names>M</given-names></name><name><surname>Miyazaki</surname><given-names>N</given-names></name><name><surname>Yoshida</surname><given-names>A</given-names></name><etal/></person-group>
<year>2011</year>
<article-title>Crystal structure of the cis-dimer of nectin-1: implications for the architecture of cell-cell junctions.</article-title>
<source>J Biol Chem</source>
<volume>286</volume>
<fpage>12659</fpage>
<lpage>12669</lpage>
<pub-id pub-id-type="pmid">21325282</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Cocchi1">
        <label>27</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cocchi</surname><given-names>F</given-names></name><name><surname>Lopez</surname><given-names>M</given-names></name><name><surname>Menotti</surname><given-names>L</given-names></name><name><surname>Aoubala</surname><given-names>M</given-names></name><name><surname>Dubreuil</surname><given-names>P</given-names></name><etal/></person-group>
<year>1998</year>
<article-title>The V domain of herpesvirus Ig-like receptor (HIgR) contains a major functional region in herpes simplex virus-1 entry into cells and interacts physically with the viral glycoprotein D.</article-title>
<source>Proc Natl Acad Sci U S A</source>
<volume>95</volume>
<fpage>15700</fpage>
<lpage>15705</lpage>
<pub-id pub-id-type="pmid">9861033</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Krummenacher4">
        <label>28</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Krummenacher</surname><given-names>C</given-names></name><name><surname>Rux</surname><given-names>AH</given-names></name><name><surname>Whitbeck</surname><given-names>JC</given-names></name><name><surname>Ponce de Leon</surname><given-names>M</given-names></name><name><surname>Lou</surname><given-names>H</given-names></name><etal/></person-group>
<year>1999</year>
<article-title>The first immunoglobulin-like domain of HveC is sufficient to bind herpes simplex virus gD with full affinity while the third domain is involved in oligomerization of HveC.</article-title>
<source>J Virol</source>
<volume>73</volume>
<fpage>8127</fpage>
<lpage>8137</lpage>
<pub-id pub-id-type="pmid">10482562</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Cocchi2">
        <label>29</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cocchi</surname><given-names>F</given-names></name><name><surname>Lopez</surname><given-names>M</given-names></name><name><surname>Dubreuil</surname><given-names>P</given-names></name><name><surname>Campadelli Fiume</surname><given-names>G</given-names></name><name><surname>Menotti</surname><given-names>L</given-names></name></person-group>
<year>2001</year>
<article-title>Chimeric nectin1-poliovirus receptor molecules identify a nectin1 region functional in herpes simplex virus entry.</article-title>
<source>J Virol</source>
<volume>75</volume>
<fpage>7987</fpage>
<lpage>7994</lpage>
<pub-id pub-id-type="pmid">11483743</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Krummenacher5">
        <label>30</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Krummenacher</surname><given-names>C</given-names></name><name><surname>Baribaud</surname><given-names>I</given-names></name><name><surname>Ponce de Leon</surname><given-names>M</given-names></name><name><surname>Whitbeck</surname><given-names>JC</given-names></name><name><surname>Lou</surname><given-names>H</given-names></name><etal/></person-group>
<year>2000</year>
<article-title>Localization of a binding site for herpes simplex virus glycoprotein D on the herpesvirus entry mediator C by using anti-receptor monoclonal antibodies.</article-title>
<source>J Virol</source>
<volume>74</volume>
<fpage>10863</fpage>
<lpage>10872</lpage>
<pub-id pub-id-type="pmid">11069980</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Takai1">
        <label>31</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Takai</surname><given-names>Y</given-names></name><name><surname>Miyoshi</surname><given-names>J</given-names></name><name><surname>Ikeda</surname><given-names>W</given-names></name><name><surname>Ogita</surname><given-names>H</given-names></name></person-group>
<year>2008</year>
<article-title>Nectins and nectin-like molecules: roles in contact inhibition of cell movement and proliferation.</article-title>
<source>Nat Rev Mol Cell Biol</source>
<volume>9</volume>
<fpage>603</fpage>
<lpage>615</lpage>
<pub-id pub-id-type="pmid">18648374</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Krummenacher6">
        <label>32</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Krummenacher</surname><given-names>C</given-names></name><name><surname>Baribaud</surname><given-names>I</given-names></name><name><surname>Sanzo</surname><given-names>JF</given-names></name><name><surname>Cohen</surname><given-names>GH</given-names></name><name><surname>Eisenberg</surname><given-names>RJ</given-names></name></person-group>
<year>2002</year>
<article-title>Effects of herpes simplex virus on structure and function of nectin- 1/HveC.</article-title>
<source>J Virol</source>
<volume>76</volume>
<fpage>2424</fpage>
<lpage>2433</lpage>
<pub-id pub-id-type="pmid">11836420</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Sakisaka1">
        <label>33</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sakisaka</surname><given-names>T</given-names></name><name><surname>Taniguchi</surname><given-names>T</given-names></name><name><surname>Nakanishi</surname><given-names>H</given-names></name><name><surname>Takahashi</surname><given-names>K</given-names></name><name><surname>Miyahara</surname><given-names>M</given-names></name><etal/></person-group>
<year>2001</year>
<article-title>Requirement of interaction of nectin-1alpha/HveC with afadin for efficient cell-cell spread of herpes simplex virus type 1.</article-title>
<source>J Virol</source>
<volume>75</volume>
<fpage>4734</fpage>
<lpage>4743</lpage>
<pub-id pub-id-type="pmid">11312345</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-McCoy1">
        <label>34</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McCoy</surname><given-names>AJ</given-names></name><name><surname>Grosse-Kunstleve</surname><given-names>RW</given-names></name><name><surname>Adams</surname><given-names>PD</given-names></name><name><surname>Winn</surname><given-names>MD</given-names></name><name><surname>Storoni</surname><given-names>LC</given-names></name><etal/></person-group>
<year>2007</year>
<article-title>Phaser crystallographic software.</article-title>
<source>J Appl Crystallogr</source>
<volume>40</volume>
<fpage>658</fpage>
<lpage>674</lpage>
<pub-id pub-id-type="pmid">19461840</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Skubak1">
        <label>35</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Skubak</surname><given-names>P</given-names></name><name><surname>Murshudov</surname><given-names>GN</given-names></name><name><surname>Pannu</surname><given-names>NS</given-names></name></person-group>
<year>2004</year>
<article-title>Direct incorporation of experimental phase information in model refinement.</article-title>
<source>Acta Crystallogr D</source>
<volume>60</volume>
<fpage>2196</fpage>
<lpage>2201</lpage>
<pub-id pub-id-type="pmid">15572772</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Spear1">
        <label>36</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Spear</surname><given-names>PG</given-names></name><name><surname>Manoj</surname><given-names>S</given-names></name><name><surname>Yoon</surname><given-names>M</given-names></name><name><surname>Jogger</surname><given-names>CR</given-names></name><name><surname>Zago</surname><given-names>A</given-names></name><etal/></person-group>
<year>2006</year>
<article-title>Different receptors binding to distinct interfaces on herpes simplex virus gD can trigger events leading to cell fusion and viral entry.</article-title>
<source>Virology</source>
<volume>344</volume>
<fpage>17</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="pmid">16364731</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Geraghty1">
        <label>37</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Geraghty</surname><given-names>RJ</given-names></name><name><surname>Fridberg</surname><given-names>A</given-names></name><name><surname>Krummenacher</surname><given-names>C</given-names></name><name><surname>Cohen</surname><given-names>GH</given-names></name><name><surname>Eisenberg</surname><given-names>RJ</given-names></name><etal/></person-group>
<year>2001</year>
<article-title>Use of chimeric nectin-1(HveC)-related receptors to demonstrate that ability to bind alphaherpesvirus gD is not necessarily sufficient for viral entry.</article-title>
<source>Virology</source>
<volume>285</volume>
<fpage>366</fpage>
<lpage>375</lpage>
<pub-id pub-id-type="pmid">11437670</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Zhang1">
        <label>38</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Mueller</surname><given-names>S</given-names></name><name><surname>Morais</surname><given-names>MC</given-names></name><name><surname>Bator</surname><given-names>CM</given-names></name><name><surname>Bowman</surname><given-names>VD</given-names></name><etal/></person-group>
<year>2008</year>
<article-title>Crystal structure of CD155 and electron microscopic studies of its complexes with polioviruses.</article-title>
<source>Proc Natl Acad Sci U S A</source>
<volume>105</volume>
<fpage>18284</fpage>
<lpage>18289</lpage>
<pub-id pub-id-type="pmid">19011098</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Kwong1">
        <label>39</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kwong</surname><given-names>PD</given-names></name><name><surname>Wyatt</surname><given-names>R</given-names></name><name><surname>Robinson</surname><given-names>J</given-names></name><name><surname>Sweet</surname><given-names>RW</given-names></name><name><surname>Sodroski</surname><given-names>J</given-names></name><etal/></person-group>
<year>1998</year>
<article-title>Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody.</article-title>
<source>Nature</source>
<volume>393</volume>
<fpage>648</fpage>
<lpage>659</lpage>
<pub-id pub-id-type="pmid">9641677</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Bewley1">
        <label>40</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bewley</surname><given-names>MC</given-names></name><name><surname>Springer</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>YB</given-names></name><name><surname>Freimuth</surname><given-names>P</given-names></name><name><surname>Flanagan</surname><given-names>JM</given-names></name></person-group>
<year>1999</year>
<article-title>Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR.</article-title>
<source>Science</source>
<volume>286</volume>
<fpage>1579</fpage>
<lpage>1583</lpage>
<pub-id pub-id-type="pmid">10567268</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Kirchner1">
        <label>41</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kirchner</surname><given-names>E</given-names></name><name><surname>Guglielmi</surname><given-names>KM</given-names></name><name><surname>Strauss</surname><given-names>HM</given-names></name><name><surname>Dermody</surname><given-names>TS</given-names></name><name><surname>Stehle</surname><given-names>T</given-names></name></person-group>
<year>2008</year>
<article-title>Structure of reovirus sigma1 in complex with its receptor junctional adhesion molecule-A.</article-title>
<source>PLoS Pathog</source>
<volume>4</volume>
<fpage>e1000235</fpage>
<pub-id pub-id-type="pmid">19079583</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Menotti1">
        <label>42</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Menotti</surname><given-names>L</given-names></name><name><surname>Cerretani</surname><given-names>A</given-names></name><name><surname>Hengel</surname><given-names>H</given-names></name><name><surname>Campadelli-Fiume</surname><given-names>G</given-names></name></person-group>
<year>2008</year>
<article-title>Construction of a fully retargeted herpes simplex virus 1 recombinant capable of entering cells solely via human epidermal growth factor receptor 2.</article-title>
<source>J Virol</source>
<volume>82</volume>
<fpage>10153</fpage>
<lpage>10161</lpage>
<pub-id pub-id-type="pmid">18684832</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Martinez1">
        <label>43</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Martinez</surname><given-names>WM</given-names></name><name><surname>Spear</surname><given-names>PG</given-names></name></person-group>
<year>2002</year>
<article-title>Amino acid substitutions in the V domain of nectin-1 (HveC) that impair entry activity for herpes simplex virus types 1 and 2 but not for Pseudorabies virus or bovine herpesvirus 1.</article-title>
<source>J Virol</source>
<volume>76</volume>
<fpage>7255</fpage>
<lpage>7262</lpage>
<pub-id pub-id-type="pmid">12072525</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Uchida1">
        <label>44</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Uchida</surname><given-names>H</given-names></name><name><surname>Shah</surname><given-names>WA</given-names></name><name><surname>Ozuer</surname><given-names>A</given-names></name><name><surname>Frampton</surname><given-names>AR</given-names><suffix>Jr</suffix></name><name><surname>Goins</surname><given-names>WF</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>Generation of herpesvirus entry mediator (HVEM)-restricted herpes simplex virus type 1 mutant viruses: resistance of HVEM-expressing cells and identification of mutations that rescue nectin-1 recognition.</article-title>
<source>J Virol</source>
<volume>83</volume>
<fpage>2951</fpage>
<lpage>2961</lpage>
<pub-id pub-id-type="pmid">19129446</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Whitbeck1">
        <label>45</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Whitbeck</surname><given-names>JC</given-names></name><name><surname>Muggeridge</surname><given-names>MI</given-names></name><name><surname>Rux</surname><given-names>A</given-names></name><name><surname>Hou</surname><given-names>W</given-names></name><name><surname>Krummenacher</surname><given-names>C</given-names></name><etal/></person-group>
<year>1999</year>
<article-title>The major neutralizing antigenic site on herpes simplex virus glycoprotein D overlaps a receptor-binding domain.</article-title>
<source>J Virol</source>
<volume>73</volume>
<fpage>9879</fpage>
<lpage>9890</lpage>
<pub-id pub-id-type="pmid">10559300</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Connolly3">
        <label>46</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Connolly</surname><given-names>SA</given-names></name><name><surname>Landsburg</surname><given-names>DJ</given-names></name><name><surname>Carfi</surname><given-names>A</given-names></name><name><surname>Whitbeck</surname><given-names>JC</given-names></name><name><surname>Zuo</surname><given-names>Y</given-names></name><etal/></person-group>
<year>2005</year>
<article-title>Potential nectin-1 binding site on herpes simplex virus glycoprotein D.</article-title>
<source>J Virol</source>
<volume>79</volume>
<fpage>1282</fpage>
<lpage>1295</lpage>
<pub-id pub-id-type="pmid">15613355</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Struyf1">
        <label>47</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Struyf</surname><given-names>F</given-names></name><name><surname>Martinez</surname><given-names>WM</given-names></name><name><surname>Spear</surname><given-names>PG</given-names></name></person-group>
<year>2002</year>
<article-title>Mutations in the N-terminal domains of nectin-1 and nectin-2 reveal differences in requirements for entry of various alphaherpesviruses and for nectin-nectin interactions.</article-title>
<source>J Virol</source>
<volume>76</volume>
<fpage>12940</fpage>
<lpage>12950</lpage>
<pub-id pub-id-type="pmid">12438620</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Dong1">
        <label>48</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dong</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>F</given-names></name><name><surname>Gong</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Lin</surname><given-names>P</given-names></name><etal/></person-group>
<year>2006</year>
<article-title>Crystal structure of the V domain of human Nectin-like molecule-1/Syncam3/Tsll1/Igsf4b, a neural tissue-specific immunoglobulin-like cell-cell adhesion molecule.</article-title>
<source>J Biol Chem</source>
<volume>281</volume>
<fpage>10610</fpage>
<lpage>10617</lpage>
<pub-id pub-id-type="pmid">16467305</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-vanRaaij1">
        <label>49</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>van Raaij</surname><given-names>MJ</given-names></name><name><surname>Chouin</surname><given-names>E</given-names></name><name><surname>van der Zandt</surname><given-names>H</given-names></name><name><surname>Bergelson</surname><given-names>JM</given-names></name><name><surname>Cusack</surname><given-names>S</given-names></name></person-group>
<year>2000</year>
<article-title>Dimeric structure of the coxsackievirus and adenovirus receptor D1 domain at 1.7 Ã resolution.</article-title>
<source>Structure</source>
<volume>8</volume>
<fpage>1147</fpage>
<lpage>1155</lpage>
<pub-id pub-id-type="pmid">11080637</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Hashiguchi1">
        <label>50</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hashiguchi</surname><given-names>T</given-names></name><name><surname>Ose</surname><given-names>T</given-names></name><name><surname>Kubota</surname><given-names>M</given-names></name><name><surname>Maita</surname><given-names>N</given-names></name><name><surname>Kamishikiryo</surname><given-names>J</given-names></name><etal/></person-group>
<year>2011</year>
<article-title>Structure of the measles virus hemagglutinin bound to its cellular receptor SLAM.</article-title>
<source>Nat Struct Mol Biol</source>
<volume>18</volume>
<fpage>135</fpage>
<lpage>141</lpage>
<pub-id pub-id-type="pmid">21217702</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Connolly4">
        <label>51</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Connolly</surname><given-names>SA</given-names></name><name><surname>Landsburg</surname><given-names>DJ</given-names></name><name><surname>Carfi</surname><given-names>A</given-names></name><name><surname>Wiley</surname><given-names>DC</given-names></name><name><surname>Eisenberg</surname><given-names>RJ</given-names></name><etal/></person-group>
<year>2002</year>
<article-title>Structure-based analysis of the herpes simplex virus glycoprotein D binding site present on herpesvirus entry mediator HveA(HVEM).</article-title>
<source>J Virol</source>
<volume>76</volume>
<fpage>10894</fpage>
<lpage>10904</lpage>
<pub-id pub-id-type="pmid">12368332</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Lazear1">
        <label>52</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lazear</surname><given-names>E</given-names></name><name><surname>Carfi</surname><given-names>A</given-names></name><name><surname>Whitbeck</surname><given-names>JC</given-names></name><name><surname>Cairns</surname><given-names>TM</given-names></name><name><surname>Krummenacher</surname><given-names>C</given-names></name><etal/></person-group>
<year>2008</year>
<article-title>Engineered disulfide bonds in herpes simplex virus type 1 gD separate receptor binding from fusion initiation and viral entry.</article-title>
<source>J Virol</source>
<volume>82</volume>
<fpage>700</fpage>
<lpage>709</lpage>
<pub-id pub-id-type="pmid">18032483</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Manoj1">
        <label>53</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Manoj</surname><given-names>S</given-names></name><name><surname>Jogger</surname><given-names>CR</given-names></name><name><surname>Myscofski</surname><given-names>D</given-names></name><name><surname>Yoon</surname><given-names>M</given-names></name><name><surname>Spear</surname><given-names>PG</given-names></name></person-group>
<year>2004</year>
<article-title>Mutations in herpes simplex virus glycoprotein D that prevent cell entry via nectins and alter cell tropism.</article-title>
<source>Proc Natl Acad Sci U S A</source>
<volume>101</volume>
<fpage>12414</fpage>
<lpage>12421</lpage>
<pub-id pub-id-type="pmid">15273289</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Yoon2">
        <label>54</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yoon</surname><given-names>M</given-names></name><name><surname>Spear</surname><given-names>PG</given-names></name></person-group>
<year>2002</year>
<article-title>Disruption of adherens junctions liberates nectin-1 to serve as receptor for herpes simplex virus and pseudorabies virus entry.</article-title>
<source>J Virol</source>
<volume>76</volume>
<fpage>7203</fpage>
<lpage>7208</lpage>
<pub-id pub-id-type="pmid">12072519</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Bergelson1">
        <label>55</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bergelson</surname><given-names>JM</given-names></name><name><surname>Cunningham</surname><given-names>JA</given-names></name><name><surname>Droguett</surname><given-names>G</given-names></name><name><surname>Kurt-Jones</surname><given-names>EA</given-names></name><name><surname>Krithivas</surname><given-names>A</given-names></name><etal/></person-group>
<year>1997</year>
<article-title>Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5.</article-title>
<source>Science</source>
<volume>275</volume>
<fpage>1320</fpage>
<lpage>1323</lpage>
<pub-id pub-id-type="pmid">9036860</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Mendelsohn1">
        <label>56</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mendelsohn</surname><given-names>CL</given-names></name><name><surname>Wimmer</surname><given-names>E</given-names></name><name><surname>Racaniello</surname><given-names>VR</given-names></name></person-group>
<year>1989</year>
<article-title>Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily.</article-title>
<source>Cell</source>
<volume>56</volume>
<fpage>855</fpage>
<lpage>865</lpage>
<pub-id pub-id-type="pmid">2538245</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Barton1">
        <label>57</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Barton</surname><given-names>ES</given-names></name><name><surname>Forrest</surname><given-names>JC</given-names></name><name><surname>Connolly</surname><given-names>JL</given-names></name><name><surname>Chappell</surname><given-names>JD</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><etal/></person-group>
<year>2001</year>
<article-title>Junction adhesion molecule is a receptor for reovirus.</article-title>
<source>Cell</source>
<volume>104</volume>
<fpage>441</fpage>
<lpage>451</lpage>
<pub-id pub-id-type="pmid">11239401</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Walters1">
        <label>58</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Walters</surname><given-names>RW</given-names></name><name><surname>Freimuth</surname><given-names>P</given-names></name><name><surname>Moninger</surname><given-names>TO</given-names></name><name><surname>Ganske</surname><given-names>I</given-names></name><name><surname>Zabner</surname><given-names>J</given-names></name><etal/></person-group>
<year>2002</year>
<article-title>Adenovirus fiber disrupts CAR-mediated intercellular adhesion allowing virus escape.</article-title>
<source>Cell</source>
<volume>110</volume>
<fpage>789</fpage>
<lpage>799</lpage>
<pub-id pub-id-type="pmid">12297051</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Menotti2">
        <label>59</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Menotti</surname><given-names>L</given-names></name><name><surname>Cocchi</surname><given-names>F</given-names></name><name><surname>Campadelli-Fiume</surname><given-names>G</given-names></name></person-group>
<year>2002</year>
<article-title>Critical residues in the CCâ² ridge of the human nectin1 receptor V domain enable herpes simplex virus entry into the cell and act synergistically with the downstream region.</article-title>
<source>Virology</source>
<volume>301</volume>
<fpage>6</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="pmid">12359441</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Geraghty2">
        <label>60</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Geraghty</surname><given-names>RJ</given-names></name><name><surname>Krummenacher</surname><given-names>C</given-names></name><name><surname>Eisenberg</surname><given-names>RJ</given-names></name><name><surname>Cohen</surname><given-names>GH</given-names></name><name><surname>Spear</surname><given-names>PG</given-names></name></person-group>
<year>1998</year>
<article-title>Entry of alphaherpesviruses mediated by poliovirus receptor related protein 1 and poliovirus receptor.</article-title>
<source>Science</source>
<volume>280</volume>
<fpage>1618</fpage>
<lpage>1620</lpage>
<pub-id pub-id-type="pmid">9616127</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Willis1">
        <label>61</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Willis</surname><given-names>SH</given-names></name><name><surname>Rux</surname><given-names>AH</given-names></name><name><surname>Peng</surname><given-names>C</given-names></name><name><surname>Whitbeck</surname><given-names>JC</given-names></name><name><surname>Nicola</surname><given-names>AV</given-names></name><etal/></person-group>
<year>1998</year>
<article-title>Examination of the kinetics of herpes simplex virus glycoprotein D binding to the herpesvirus entry mediator, using surface plasmon resonance.</article-title>
<source>J Virol</source>
<volume>72</volume>
<fpage>5937</fpage>
<lpage>5947</lpage>
<pub-id pub-id-type="pmid">9621056</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Gianni1">
        <label>62</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gianni</surname><given-names>T</given-names></name><name><surname>Amasio</surname><given-names>M</given-names></name><name><surname>Campadelli-Fiume</surname><given-names>G</given-names></name></person-group>
<year>2009</year>
<article-title>Herpes simplex virus gD forms distinct complexes with fusion executors gB and gH/gL in part through the C-terminal profusion domain.</article-title>
<source>J Biol Chem</source>
<volume>284</volume>
<fpage>17370</fpage>
<lpage>17382</lpage>
<pub-id pub-id-type="pmid">19386594</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-PerezRomero1">
        <label>63</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Perez-Romero</surname><given-names>P</given-names></name><name><surname>Perez</surname><given-names>A</given-names></name><name><surname>Capul</surname><given-names>A</given-names></name><name><surname>Montgomery</surname><given-names>R</given-names></name><name><surname>Fuller</surname><given-names>AO</given-names></name></person-group>
<year>2005</year>
<article-title>Herpes simplex virus entry mediator associates in infected cells in a complex with viral proteins gD and at least gH.</article-title>
<source>J Virol</source>
<volume>79</volume>
<fpage>4540</fpage>
<lpage>4544</lpage>
<pub-id pub-id-type="pmid">15767456</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Cocchi3">
        <label>64</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cocchi</surname><given-names>F</given-names></name><name><surname>Fusco</surname><given-names>D</given-names></name><name><surname>Menotti</surname><given-names>L</given-names></name><name><surname>Gianni</surname><given-names>T</given-names></name><name><surname>Eisenberg</surname><given-names>RJ</given-names></name><etal/></person-group>
<year>2004</year>
<article-title>The soluble ectodomain of herpes simplex virus gD contains a membrane-proximal pro-fusion domain and suffices to mediate virus entry.</article-title>
<source>Proc Natl Acad Sci U S A</source>
<volume>101</volume>
<fpage>7445</fpage>
<lpage>7450</lpage>
<pub-id pub-id-type="pmid">15123804</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Zhou1">
        <label>65</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhou</surname><given-names>G</given-names></name><name><surname>Ye</surname><given-names>GJ</given-names></name><name><surname>Debinski</surname><given-names>W</given-names></name><name><surname>Roizman</surname><given-names>B</given-names></name></person-group>
<year>2002</year>
<article-title>Engineered herpes simplex virus 1 is dependent on IL13Ralpha 2 receptor for cell entry and independent of glycoprotein D receptor interaction.</article-title>
<source>Proc Natl Acad Sci U S A</source>
<volume>99</volume>
<fpage>15124</fpage>
<lpage>15129</lpage>
<pub-id pub-id-type="pmid">12417744</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Zago1">
        <label>66</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zago</surname><given-names>A</given-names></name><name><surname>Jogger</surname><given-names>CR</given-names></name><name><surname>Spear</surname><given-names>PG</given-names></name></person-group>
<year>2004</year>
<article-title>Use of herpes simplex virus and pseudorabies virus chimeric glycoprotein D molecules to identify regions critical for membrane fusion.</article-title>
<source>Proc Natl Acad Sci U S A</source>
<volume>101</volume>
<fpage>17498</fpage>
<lpage>17503</lpage>
<pub-id pub-id-type="pmid">15583135</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Zhou2">
        <label>67</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhou</surname><given-names>G</given-names></name><name><surname>Avitabile</surname><given-names>E</given-names></name><name><surname>Campadelli-Fiume</surname><given-names>G</given-names></name><name><surname>Roizman</surname><given-names>B</given-names></name></person-group>
<year>2003</year>
<article-title>The domains of glycoprotein D required to block apoptosis induced by herpes simplex virus 1 are largely distinct from those involved in cell-cell fusion and binding to nectin1.</article-title>
<source>J Virol</source>
<volume>77</volume>
<fpage>3759</fpage>
<lpage>3767</lpage>
<pub-id pub-id-type="pmid">12610150</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Kamiyama1">
        <label>68</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kamiyama</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>G</given-names></name><name><surname>Roizman</surname><given-names>B</given-names></name></person-group>
<year>2006</year>
<article-title>Herpes simplex virus 1 recombinant virions exhibiting the amino terminal fragment of urokinase-type plasminogen activator can enter cells via the cognate receptor.</article-title>
<source>Gene Ther</source>
<volume>13</volume>
<fpage>621</fpage>
<lpage>629</lpage>
<pub-id pub-id-type="pmid">16292350</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Menotti3">
        <label>69</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Menotti</surname><given-names>L</given-names></name><name><surname>Cerretani</surname><given-names>A</given-names></name><name><surname>Campadelli-Fiume</surname><given-names>G</given-names></name></person-group>
<year>2006</year>
<article-title>A herpes simplex virus recombinant that exhibits a single-chain antibody to HER2/neu enters cells through the mammary tumor receptor, independently of the gD receptors.</article-title>
<source>J Virol</source>
<volume>80</volume>
<fpage>5531</fpage>
<lpage>5539</lpage>
<pub-id pub-id-type="pmid">16699034</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Menotti4">
        <label>70</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Menotti</surname><given-names>L</given-names></name><name><surname>Nicoletti</surname><given-names>G</given-names></name><name><surname>Gatta</surname><given-names>V</given-names></name><name><surname>Croci</surname><given-names>S</given-names></name><name><surname>Landuzzi</surname><given-names>L</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells.</article-title>
<source>Proc Natl Acad Sci U S A</source>
<volume>106</volume>
<fpage>9039</fpage>
<lpage>9044</lpage>
<pub-id pub-id-type="pmid">19458262</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Zhou3">
        <label>71</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhou</surname><given-names>G</given-names></name><name><surname>Roizman</surname><given-names>B</given-names></name></person-group>
<year>2007</year>
<article-title>Separation of receptor-binding and profusogenic domains of glycoprotein D of herpes simplex virus 1 into distinct interacting proteins.</article-title>
<source>Proc Natl Acad Sci U S A</source>
<volume>104</volume>
<fpage>4142</fpage>
<lpage>4146</lpage>
<pub-id pub-id-type="pmid">17360490</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Otwinowski1">
        <label>72</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Otwinowski</surname><given-names>Z</given-names></name><name><surname>Minor</surname><given-names>W</given-names></name></person-group>
<year>1997</year>
<article-title>Processing of X-ray diffraction data collected in oscillation mode.</article-title>
<source>Methods Enzymol</source>
<volume>276</volume>
<fpage>307</fpage>
<lpage>326</lpage>
</element-citation>
      </ref>
      <ref id="ppat.1002277-CCP41">
        <label>73</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>CCP4</surname></name></person-group>
<year>1994</year>
<article-title>The CCP4 suite: programs for protein crystallography.</article-title>
<source>Acta Crystallogr D</source>
<volume>50</volume>
<fpage>760</fpage>
<lpage>763</lpage>
<pub-id pub-id-type="pmid">15299374</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Yeates1">
        <label>74</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yeates</surname><given-names>TO</given-names></name></person-group>
<year>1997</year>
<article-title>Detecting and overcoming crystal twinning.</article-title>
<source>Methods Enzymol</source>
<volume>276</volume>
<fpage>344</fpage>
<lpage>358</lpage>
</element-citation>
      </ref>
      <ref id="ppat.1002277-Adams1">
        <label>75</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Adams</surname><given-names>PD</given-names></name><name><surname>Afonine</surname><given-names>PV</given-names></name><name><surname>Bunkoczi</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>VB</given-names></name><name><surname>Davis</surname><given-names>IW</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>PHENIX: a comprehensive Python-based system for macromolecular structure solution.</article-title>
<source>Acta Crystallogr D</source>
<volume>66</volume>
<fpage>213</fpage>
<lpage>221</lpage>
<pub-id pub-id-type="pmid">20124702</pub-id></element-citation>
      </ref>
      <ref id="ppat.1002277-Krummenacher7">
        <label>76</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Krummenacher</surname><given-names>C</given-names></name><name><surname>Baribaud</surname><given-names>I</given-names></name><name><surname>Eisenberg</surname><given-names>RJ</given-names></name><name><surname>Cohen</surname><given-names>GH</given-names></name></person-group>
<year>2003</year>
<article-title>Cellular localization of nectin-1 and glycoprotein D during herpes simplex virus infection.</article-title>
<source>J Virol</source>
<volume>77</volume>
<fpage>8985</fpage>
<lpage>8999</lpage>
<pub-id pub-id-type="pmid">12885915</pub-id></element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>